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Abstract

THE ROLE OF OPSONIN-INDEPENDENT BACTERIAL ADHERENCE IN THE
PATHOGENESIS OF LEGIONNAIRES' DISEASE.
by
Frank C. Gibson III
University of New Hampshire, May, 1994.

Legionella pneumopNIa is a facultative intracellular bacterial
pathogen which initiates infection of the human host by adhering to
macrophages in the alveoli of the lung following which internalization and
intracellular multiplication occurs. In this study a novel mechanism of
opsonin-independent attachm ent for this organism to host cells was
identified. L. pneumophila serogroup 1, strain Nottingham N7, and U-937
cells as well as primary guinea pig alveolar macrophages were used to
study this adherence phenomenon.
A variety o f assay methods were used to evaluate the nature of this
binding event: transmission electron microscopy and scanning electron
microscopy were used to visualize the uptake and replicative processes
while organism enumeration as a measure o f adherence was
accomplished using viable bacterial cell colony counts and indirect
immunofluorescence studies. It was shown that L. pneumophila adhered

xii

to U-937 cells in the absence of com plem ent and a com plete infectious
cycle for the organism was found. These data confirmed previously
identified stages of phagocytic host cell interaction including uptake,
intracellular replication and release of progeny bacteria.
The chemical nature of the L pneumophila bacterial 'adhesin' and
the host cell ‘ receptor* in binding studies were investigated. The results
from both com petitive binding and surface treatm ent studies suggested
the nature of the putative adhesins and receptor moieties associated with
successful attachm ent of L pneumophila to these host cells. Glycolipids on
host cell surfaces and proteins or glycoproteins on Legionella membranes
function to facilitate binding of bacteria prior to engulfment.
Monoclonal antibodies specific for complement receptors CR1, CR3
and CR4 were used in blocking studies and these indicated that these
molecules were not involved in the recognition of legionellae. These results
indicate the im portance of opsonin-independent binding mechanisms for
L. pneumophila to host cells and shed new light on our understanding of
cellular infection by L. pneumophila.

xiii

SECTION I
HISTORICAL PERSPECTIVE OF THE GENUS LEGIONELLAAND
LEGIONNAIRES’ DISEASE.
1.1 Background and Objectives of Study
Legionella pneumophila Is the major organism responsible for the
potentially life-threatening human pneumonic illness called Legionnaires'
disease. Outbreaks of this disease either occur in explosive, spectacular
fashion or take the form o f sporadic infections and in either case these
may be of community based or nosocomial origin (68 , 77, 175). Although
the most notorious outbreak occurred 18 years ago among American
Legionnaires in Philadelphia, PA (68), to which this disease owes its name,
many outbreaks have occurred since then. Furthermore, numerous
outbreaks have been serologically diagnosed retrospectively prior to 1976
(97,145,173). It was from the Philadelphia epidemic that two very
important points were forthcoming: first, an entire family of previously
unidentified microorganisms were identified and second, physicians as well
as researchers were forcibly reminded that infectious diseases remain a
major problem afflicting humankind.
Since the late 1970's, several new microbial diseases have been
identified and these include such newly recognized important infections as
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Lyme's disease, Cam pylobacter enteritis and acquired immune deficiency
syndrome (AIDS) to name but a few. Understanding the physical nature of
Legionella, identifying aspects of the environment that influence its
proliferation together with resolving host involvements in the establishment
of Legionnaires' disease are essential if this pathogen is to be brought
under control.
This bacterium is a facultative, intracellular, respiratory pathogen that
induces lobar pneumonia in those infected. The inhalation o f aerosolized
water droplets contam inated with L. pneumophila is the route by which this
organism gains access into the host's respiratory network and begins the
colonization of the resident macrophages in the lung (77). This process is a
necessary prerequisite for the initiation of disease.
Aggressive antimicrobial chemotherapy has been shown to reduce
the likelihood of patient mortality (68). Alternatives to traditional antibiotic
treatm ent are currently being sought for the control of Legionnaires'
disease. This is particularly important as chemotherapy alone will not
prevent the initiation of disease and may not on occasion prevent the
outcom e of severe infection. In addition, recurrent infections following
antibiotic therapy have been reported. Treatment regimes often must be
broad-ranging in their scope and, reflecting the im portance of cellmediated immunity, may require the use of immune system-enhancing
molecules such as interferon-gamma (IFN-7) and interleukins to augment
chem otherapy (15,69,189,190). Moreover, these treatments may be

2

most effective if used in conjunction with traditional antibiotic regimes. The
developm ent of combination therapy programs will undoubtedly assist in
the effective control of this pathogen.
The purpose of this study was to investigate and evaluate an
alternative mechanism of Legionella attachm ent to host cells involving an
opsonin-independent process. U-937 cells, transformed human
macrophage-like cells and guinea pig alveolar m acrophage (GAM) cells
were used to evaluate the adherence of Legionella by this mechanism. By
identifying the bacterial attachm ent mechanisms the results o f this work
should augm ent current knowledge on understanding the fundamental
processes o f Legionella infection of host cells and may assist toward the
developm ent of a suitable vaccine for Legionnaires' disease.

1.2 The Problem
1.2.1 Background
Legionnaires' disease constitutes a medical problem o f significant
proportions and death due to infection is not uncommon. More data is
required on the mechanisms of disease induction. Legionellosis is the
common name for an illness which consists of two disparate disease
conditions: Legionnaires' disease and Pontiac fever. These conditions are
caused by what appear to be phenotypically and genotypically identical
organisms. Legionnaires' disease is a lobar pneumonia, which received its
name from the Philadelphia epidemic of 1976 (68,114). It is the more
serious condition caused by L pneumophila and patient recovery
3

inevitably requires m edical intervention. Pontiac fever, on the other hand,
acquired its name from an outbreak in Pontiac, Ml, in 1968 and is a selflimiting respiratory illness which presents with flu-like symptoms (77). Factors
such as the health of the host, the infectious dose, the method of exposure
and the expression of bacterial virulence determinants by the organism
undoubtedly offer some explanation for these tw o variations in disease
expression.

1.2.2 Philadelphia Outbreak
Immediately following the annual convention of the American
Legion held in July and August of 1976 at the Bellevue-Stratford hotel in
Philadelphia. PA, the world witnessed a spectacular epidemic of acute
febrile respiratory disease (68). The etiology of this disease remained
unresolved for several months. In the epidem ic 216 people developed
respiratory disease and 34 died (68). Analysis of the 216 identified cases
indicated that 182 legionnaires' contracted the disease and 29 died. The
34 remaining cases were people who were at or near the hotel during the
outbreak and cam e down with so-called Broad Street pneumonia and of
these 5 died (68).
During this outbreak, several hypotheses were proposed to explain
the etiology of disease and establish the parameters for elucidating the
causative agent of this outbreak. Initial identification protocols failed to
establish the etiology of this disease in that commonly available culture
media and state-of-the-art clinical identification procedures failed to
4

provide definitive information.
In early 1977 Dr. J. McDade from the Centers for Disease Control,
using isolation procedures to identify rickettsia, demonstrate that the
etiologic agent of Legionnaires' disease was a hitherto unidentified gramnegative, rod shaped bacterium (114). Isolation process involved
inoculation of homogenized biopsied lung tissue from legionnaires' into the
yolk sac of embryonated hens' eggs. The organism replicated in the yolk
sacs which yielded pleiomorphic, carbol fuchsin staining bacilli (114) later
identified as a new family of bacteria, the Legionellaceoe (20).
Subsequent studies have retrospectively indicated that Legionella
infections of both epidem ic and sporadic forms have occurred previously
(77, 173)

1.2.3 Pontiac Fever Epidemic
Following the identification of the Legionnaires' disease bacterium,
retrospective studies were conducted to determine whether previously
unresolved outbreaks of pneumonic illness were due to infection by L
pneumophila (95,144,173). Although the Pontiac fever epidem ic
occurred in 1968, the etiologic agent was not identified a t the time of the
outbreak. This epidemic of acute, self-limiting, febrile respiratory illness
involved nearly all employees of the Oakland County Health Department in
Pontiac, Ml, during July and August of 1968 and a total of 144 persons
working a t or visiting this facility becam e ill. In general Pontiac fever
presents as a mild respiratory illness together with fever and/or chills.
5

generalized myalgia, malaise and headache (Table 1.1). The attack rate
was 95% and the mode of transmission of the pathogen was determined to
be the building's ventilation system (77). None of the infected persons died
nor was there evidence of sequelae following this outbreak. Medical
intervention is not normally required for this form of Legionella-induced
disease.
It is not understood why Legionella-induced disease presents in
these tw o quite different forms, nor are the critical factors governing
disease expression known. Examination of variations in Legionella-host
interactions will undoubtedly facilitate our understanding of the disparity in
clinical presentations and will help develop strategies to prevent
Legionella-induced deaths.

1.3 The Organism
1.3.1 Morphology
Legionellae are fastidious, gram-negative, pleiomorphic, bacilli
approximately 1-2 jim in length and 0.3-0.9 nm in width (Table 1.2). In the
lung of either infected humans or guinea pigs, short coccobacillary forms
predom inate (26, 149,156). However, when these organisms are cultured
on bacteriologic media longer forms abound and these can often be in
excess of 20 nm in length. Legionellae stain weakly gram-negative with
safranin but more strongly with carbol fuchsin. The weak safranin staining is
most likely the result of hydrophobic

6

Table 1.1: Symptomatic Presentation of Legionellosis

Legionnaires'
Disease
Historical outbreak named for: Philadelphia, PA
Attack Rate:
Incubation Period:
Symptoms:
Other sites of Infection

1-5%
2-10 days

Pontiac
Fever
Pontiac, Ml
95%
1-2 days

Pneumonia

Flu-like illness

CNS, G.l. Tract,

None

Pericardium and Kidneys
Fatality Rate:

0-40%

0%

* Legionellosis is the term applied to both illnesses. Legionnaires' disease
and Pontiac fever are the result of infection by genotypically and
phenotypically identical organisms.
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Table 1.2: Morphologic Identification of Legionella pneumophila

• Slender gram negative rods (in vivo forms are short 0.5 x l-2(im)
(in vitro forms are elongated 0.4 x 2-3|im)
• Pleiomorphic (long forms can be up to 20-50^im in length)
• Tapered ends
• Divide by non-septate, pinching, binary fission
• Possess lipopolysaccharide (major antigenic structure)
• No evidence of acid mucopolysaccharide capsule
• Motile by polar or sub-polar flagella
• Fimbriate
• Blebs on outer membrane surface
• Outer membrane and cytoplasmic membrane each lOnm thick
separated by a thin peptidoglycan layer
• Ribosomes 25nm in diameter
• Internal PpH storage granules

8

interactions between the surface of Legionella and the safranin and this
may be related to the copious amounts of branched chain fatty acids in
the organism (124) Legionella do not form spores and with the exception
of L. m icdadei which is weakly acid-fast in lung tissue (127) they are not
acid-fast.
Legionellae possess two lipid-rich membranes is separated by a
peptidoglycan layer, typical of gram-negative bacteria. In addition, the
organisms possess non-parallel sides with tapered ends (26,150, 155). The
outer membrane and cytoplasmic membrane are approximately 10 nm in
width and are separated by a thin yet identifiable peptidoglycan layer. This
structure has been demonstrated with biochem ical procedures and has
been visually identified by electron microscopy (64,155). Division occurs by
pinching binary fission (150). The lipids produced by legionellae are
complex and are not of the types typically found on other gram-negative
organisms. In addition, poly-^-hydroxybutyrate storage granules are
commonly found in Legionella (26,148, 155) The majority o f organisms in
the group are motile by polar or sub-polar flagella (150,153) which are 1420 nm in diameter and up to 8^m in length (135,153,154). The individual
monomeric flagellin proteins have a molecular mass of 47 kD, as
determined by sodium dodecyl sulphate polyacrylamide gel
electrophoresis (SDS-PAGE) (136). Unlike organisms grown on laboratory
media flagella are not usually found on organisms in lung specimens. The
expression o f flagella appears to be tem perature-dependent (136).
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Fimbriae (Rodgers) have been identified on the surface of L.
pneumophila and lipopolysaccharide (LPS) is produced abundantly (131,
150). The chem ical composition of L pneumophila LPS is similar to that of
many other gram-negative organisms and has been characterized by gas
chrom atography and mass spectroscopy (166). The composition of
Legionella LPS is typical of that for other gram-negatives with a lipid A
portion, a 2-keto-3-deoxyoctonate linker region forming 1-13% o f the
carbohydrate present and polysaccharide side chains. Species and
serotypic differences in the composition of the Legionella LPS make this an
excellent candidate for serogroup differentiation (25, 131). The LPS is
smooth and is the primary structure that elicits an antigenic response in
infected patients (71).

1.2.5 Taxonomy and Nomenclature
Brenner e t al. (19) proposed a classification system for the
Legionnaires' disease bacterium based upon DNA homology and %
guanosine and cytosine content (mol %G+C). This study demonstrated that
the organism responsible for the Philadelphia outbreak had not previously
been described. The proposed family was similarly classified as unique and
named the Legionellaceae. At the time, this group was determined to
contain one genus Legionella, and one species pneumophila.
Subsequently, numerous species have been identified and the family
currently contains 1 genus, 37 species and 3 subspecies with numerous
serogroups Gable 1.3). The range of DNA relatedness among the
10

legionellae is great and the serological variability is extensive. An
alternative to the single genus nomenclature system has been suggested
(74) with the family Legionellaceae consisting of 3 genera: (1) Legionella (L.
pneumophila), (2) Taflockia (J. micdadei) and (3) Fluoribacterithe
autofiuorescent species F. bazemanae. F. dum offiiand F. gormanii).
However, the simpler and more convenient single genus system is by far
the most universally accepted format. Isolation of Legionella from clinical
or environmental samples requires specialized media while identification
involves the use of molecular and serological procedures. Furthermore, it is
known that legionellae grow exclusively on L-cysteine containing buffered
charcoal yeast extract (BCVE-a) media (41,184) and this feature greatly
assists isolation procedures.

1.3.3 Biochemical Properties
Due to the cultural fastidiousness of this organisms and its strict
requirement for both L-cysteine and ferric salts, commonly available
laboratory media fail to grow legionellae. Indeed, initial studies dealing with
the physiology of L. pneumophila were based on the development of
media capable of cultivating the organism. The bacteria in the group are
catalase positive while oxidase, hippurate, gelatinase, and p-lactamase
expression are either variable or species dependent. In addition, some
species show a brilliant blue/white or red autofluorescence under
longwave UV and this may prove useful for identification (Table 1.3)
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Using radiolabeled amino acids and carbon sources, the
biochemical pathways of nutrient utilization for L pneumophila have been
elucidated. Pine e t al. (139) demonstrated that carbohydrates were not
used as energy sources for legionellae. Indeed, the production of
m etabolic energy is primarily derived from the breakdown o f amino acids
such as glutam ate, serine and threonine. i*C labled glutamate revealed
biosynthetic utilization with approximately 29% of this substrate traced to
lipid, 21% to protein, 16% to nucleic acid, 9% to miscellaneous
polysaccharides and 24% to small molecular weight compounds (171).
Legionellae are strict aerobes and the utilization of carbohydrates occurs
via oxidative processes as opposed to ferm entation (139, 180,181).
Glucose is metabolized and the resultant energy is used in a maintenance
rather then in a biosynthetic fashion. When glucose metabolism occurs, it is
preferentially broken down by Entner-Doudoroff and pentose-phosphate
mechanisms rather then by glycolytic processes (172).
The cellular fatty acid content, in particular branched chain fatty
acids, of L pneumophila is not consistent with that of other gram-negative
bacteria (124). Moreover, the fatty acid profile differs somewhat between
species of the genus. The majority of lipids produced by Legionella are (iso16:0) carbon compounds and in particular m ethyl-14m ethylpentadecanoic acid. Such 16-carbon compounds make up
greater then 30% of the total cellular fatty acid content of the organism.
Other lipids are produced by L. pneumophila and include the polymeric
poty-{J-hydroxybutyric acid (PBH) which was demonstrated by sudan black
12

Table 1.3: Biochemical Identification for the Genus Legionella
AF
L. pneumophila
L m icdadei
L bozemanii
L. dumoffii
L. gormanii
L. longbeachae
L jordanis
L oakridgensis
L. wadsworthii
L feelii
L sainthelensi
L anisa
L m aceachem ii
L. jamestowniensis
L. rubrilucens
L eryihra
L. hackeliae
L. speritensis
L. parisiensis
L. cherrii
L stigerwaltii
L sainticrucis
L isriaelensis
L birminhamensis
L cincinnatiensis
L. m oravica
L. brunesis
L quinlivanii
L. tucsonensis
L. fairfieldensis
L. adelaidensis
L shakespearei
L. geestiana
L bndiniensis
L. naurtarum
L. quateirensis
L. worsleiensis
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1
2

1
1

1
1
1
1
1
1
1
1
1
1
1
1
1
1

1
1
1
1
1

1
1
1
1
1
1
1
1

H/E
H/E
H/E
H/E
H/E
H
H/E
H/E
H
H/E
E
E
H/E
E
E
E
H
E
E
E
E
E
E
H
H
E
E
E
H
E
E
E
E
E
E
E
E

+
+
+
+
+
+
+

V
+
+

+
+
+

-

+
+
+
+
+
+
+W
+
+
+
+
+
+
+
+
+
+
+
+

+
+
+
+
+
+
+
+
V
+

V
+

+w

-

+W

+W

+
+
+

-

+w

+
+
+

+w

+
”

+
-

-

V
+
+
+
+/•

+

+

-

-

+
+
+
+

V
+
+
V

+
+
+
-

+
+w
+
-

+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+

+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+

+
+
BW +
BW +
BW +
+
+
+
+

+
BW(V)+
+
+
R +
R +
+
+
BW +
BW +
BW +
+
+
YG +
+
+
+
+
BW +
+
+
+
+
+
+

+= posative reaction; - = negative reaction; V= varriable results; w= weak
Cat= catalase; Ox= oxidase; p-Lac= p-lactamase; Hip= hipurate; M= Motility
GL= gelatin luquificatton; AF= autofluorescence
H= human origin; E= environmental origin
YG= yellow-green; R= red; and BW= blue-white fluorescence.
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staining and transmission electron microscopy (150, 181).
Numerous organic substrates and inorganic compounds are
necessary for the laboratory cultivation of legionellae. Initial laboratory
cultivation of legionellae on agar media demonstrated a requirement for
hemoglobin and this specific requirement for high levels of iron is met by
the addition of ferric pyrophosphate to BCYE -a m edia (143). Other ions
which are essential to Legionella cultivation include trace amounts of Ca,
Co, Cu, Mg, Mn, Na, Ni, V and Zn (143). In addition to these metal ions,
charcoal and a-ketoglutarate are important facilitators for organism
growth on laboratory media. The role played by these materials appears
to be the detoxification of BCYE-a. it is suggested although not proven that
they serve the purpose of either inactivating toxic activity of oleic acid or
of scavenging toxic oxygen radicals generated from the process of
autoclaving the yeast extract in the medium.

1.3.4 Physico-chemical Properties
In the environment legionellae experience a wide variety of
conditions which often prove bactericidal in nature; these adverse
conditions include pH variations, exposure to ultraviolet radiation (UV) and
temperature fluctuations. L pneumophila grow optimally on laboratory
m edia between pH 6.85- 6.95 a t 37°C and in the presence of 2.5% CO2 .
The bacterium is more sensitive to UV irradiation than many other gramnegative bacteria including Escherichia coli, Salmonella typhi, Serratia
14

marcescens and Pseudomonas aeruginosa (5). Organisms from
environmental or clinical isolates grow a t temperatures ranging from 25°C43°C; however, multiplication and growth do not readily occur at 50°C or
above (65, 181). Legionella selection from clinical and environmental
samples usually involves either acid or heat treatment. Edelstein e t al. (47)
showed a marked increase in Legionella recovery from clinical samples
using heat treatm ent a t 60°C for 1-2 min while Bopp et al. (18) and
Buesching et al. (20) demonstrated the usefulness of acid treatm ent of pH
2.2 for 4 min to enhanced organism recovery from both environmental and
clinical specimens. Legionella are sensitive to alkaline treatm ent (pH 8.0);
however, their sensitivity to chlorine is inconclusive as organisms in
association with protozoa appear to be more resistant to chlorine then
free-living organisms (41,97,164).

1.3.5 L. pneumophila Growth on Bacterioloaic Media
L. pneumophila are nutritionally fastidious organisms which require
strict conditions for growth. Feeley and Gorman (57) first demonstrated
that Legionella could be cultivated, but only poorly, on Muller-Hinton agar
supplemented with 1% hemoglobin and 1% IsoVitaleX in the presence of
2.5% CO 2 (57). In subsequent m edia formulations Feeley et al. (57)
optimized the growth of Legionella in the laboratory by demonstrating that
this organism has an absolute requirement for L-cysteine and ferric
pyrophosphate. This novel medium formulation was named FeeleyGorman (F-G) agar. Further physiologic studies by Feeley e t al. (56)
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demonstrated th a t media with yeast extract and activated charcoal
facilitated recovery and enhanced growth of legionellae. This new media
was called charcoal yeast extract (CYE) agar (55). A further modification
of CYE agar, introduced by Pasculle (136), involved buffering this media
with N-2-acetamido-2-aminoethanesulfonic acid (ACES) buffer to give
BCYE agar. The latest refinement introduced by Edelstein (42) added aketoglutarate to BCYE to give BCYE-a and this is the current standard for
cultivation of legionellae.
Chemically defined culture media have been developed (101,139)
but these have been used primarily to determine the nutritional
requirements of this genus. The use of defined media in conjunction with
alternative growth systems may help to identify and define growth ratedependent virulence characteristics and may aid in ascertaining the role
these factors play in the infectious process.

1.3.6 Genetics and Molecular Bioloav of the Organism
Although the understanding of Legionella interactions with host cells
at the cellular and molecular levels is paltry a t best, even less is known
about the genetic regulation and expression of those virulence factors
responsible for the establishment of disease. The majority of early genetic
investigations were directed toward the identification of Legionella in
environmental or clinical samples. Genomic sizing studies demonstrated
that the chromosome of the Legionella is approximately 2.5 x 109 daltons

16

(19). Legionellae possess a guanosine + cytosine DNA content which
ranges from 38-52 mol% and averages 39 mol % (48). Recently, 16S
ribosomal RNA studies and DNA hybridization have indicated that the
Legionellaceae are not closely related to other eubacteria (70,160). In
addition, several DNA probes are commercially available for the detection
of legionellae from either clinical or environmental specimens (42,174).
Extra chromosomal DNA in the form o f plasmids is frequently isolated
from legionellae (107,116). The 80-megadalton plasmid is common among
many strains of this organism; however, the role of these plasmids is
unknown (19,100,107,120,135). Often the plasmids of other bacteria
have been shown to harbor genes responsible for virulence traits such as
antimicrobial resistance while others directly induce virulence factors such
as toxin expression. This does not appear to be the case with Legionella in
which the presence or absence of plasmids do not modify antimicrobial
resistance patterns nor change expression o f virulence traits. It would
appear from this that plasmids apparently play no part in the expression or
establishment of disease.
Cloning of Legionella DNA fragments into other organisms has been
done successfully using E. coli as the recipient. Results however, are less
then promising when plasmids of other organisms are inserted into
Legionella (28,37). In an early study in which Legionella fragments were
cloned into E. coli an interesting virulence prolein was revealed and this
was involved with uptake o f Legionella by macrophages (29,51,52). Other
genes of L pneumophila have been successfully cloned into E. coli
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including the gene responsible for the expression of the major outer
membrane protein (80). a zinc metalloprotease (140) and a 19-kDa outer
membrane peptidoglycan-associated protein (106). In addition, several
highly conserved genes have been cloned into E. coli including the recA
gene (for homologous repair of DNA) and the groELS gene (for production
o f heat-shock proteins) (36,81,192). However. E. coli although effective as
a cloning system may not be best suited for expression o f Legionella inserts
(80). Investigators may need to consider the use of alternatives to this
vector system.

1.4 Pathogenesis
1.4.1 Human Implications
The precise processes by which legionellae infect host cells and thus
induce human disease are not well understood. To characterize the
mechanism of Legionella infection and to define the role these processes
play in Legionella pathogenesis investigations on the infectivity of the
bacterium have been performed using animal systems and a number of
primary, secondary and transformed cell lines (Table 1.4). Various animal
models have been evaluated for their ability to mimic the pathogenesis
and pathology of human disease. Hamsters, several mouse and rat strains
as well as guinea pigs have been proposed as models for human
Legionnaires' disease (10,183,191). The guinea pig has proven the most
effective animal for the evaluation of systemic disease. Recently A/J mice
have been investigated for their effectiveness a t assessing several aspects
18

of mymicing the intracellular infection seen in human disease (191). Given
that the mouse is well established for investigating other host-pathogen
interactions and has a well characterized immune system the development
of an effective mouse model for Legionnaires' disease would prove
extremely useful for evaluating L. pneumophila interactions with the
immune system in disease. Not only is the mouse immune system better
understood then that of other animals but an extensive array o f mouse
immune modulators are available and functionally characterized for use in
investigations. Such modulators include interferons, various interleukins,
tumor necrosis and colony stimulating factors. Such a model could help
elucidate the interaction of these modulating molecules with the pathogen
and might eventually influence treatm ent regimes.
To better understand the events of Legionella infection a t the cellular
level researchers have used host cells from a variety of origins. These in
vitro studies have used either transformed or non-transformed cells of
epithelial, fibroblast, polymorphonuclear and mononuclear lineage (76,87,
111,134,152). Most of these cells have been shown to support L
pneumophila infection; however, while human macrophages and
monocytes support the growth o f the organism polymorphonuclear
leukocytes (PMNL) do not. Rather, these cells support an abortive type
infection and this cell is relatively ineffective for studying cellular infectivity
of legionellae (16,88). These studies have proven important in defining
which cells support Legionella replication and in outlining the ultrastructural
events o f intracellular infection. Furthermore, the establishment of an
19

Table 1.4: Stages of Cellular Infection for Legionella pneumophila.

• Attachment

Weak Binding

Hydrophobic interactions
Hydrogen bonds
van der Waals
Electrostatic interactions

Strong Binding

Structural Interactions
Fimbriae
Flagella
Surface proteins
Lipopolysaccharide

Uptake

MIP Protein
Coiling phagocytosis
Banded enclosures

Intracellular Replication

Inhibition o f phagosome lysosome fusion
No acidification of phagosome
Ribosome-lined phagosome

Release

Unknown
Protease?
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appropriate cell model for the study of the cellular events in Legionnaires'
disease is necessary as human alveolar macrophages are not readily
available.
Since the alveolar m acrophage is the target cell in the lungs,
macrophages or macrophage-like cells appear to be most useful for
studying uptake, intracellular multiplication and release of bacterial
progeny. In addition to studies with mononuclear phagocytes,
investigations with epithelial and fibroblast cells which do not possess the
same receptors as macrophages have shown that L. pneumophila binds to
the cells and despite the lack of receptors these cells support a com plete
infectious cycle of the organism. These studies indicate that alternative
mechanisms of cellular infection exist and that certainly those processes
that occur independent of opsonins and/or com plem ent receptors may
constitute a primary mechanism by which cells are parasitized by L
pneumophila (75, 152).
A variety o f studies have extensively investigated Legionella infection
of monocytes and macrophage-like cells, as these cells are the most likely
candidates for successful establishment of human infection (75,82,111,
138,152). Those cells most frequently used include human peripheral blood
monocytes and the cell lines U-937 and HL-60 (75,87, 111, 138,152). The U937 cell has shown particular promise as a model for studying cellular
infection as this cell has been used extensively in studies of both
attachm ent and intracellular replication of Legionella (75,76,91,138,152).
These cells possess Fc and com plem ent receptors a t levels consistent with
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human alveolar macrophages (157). This, in conjunction with a similar
intracellular replication kinetics profile for L pneumophila, makes these cells
an attractive model for studying L pneumophilo-hosi cell interactions.
Furthermore, the U-937 cell has been useful for studying the interactions of
other intracellular pathogens such as Salmonella with macrophage-like
host cells (2).
Adherence of L. pneumophila to a host cell is a necessary prelude to
intracellular infection (11). Recent studies suggested that the mechanism
used by bacteria to adhere to cells was central to the establishment and
outcom e o f disease (178, 182, 187, 188). Two mechanisms of L
pneumophila attachm ent to host cells have been reported (75,88). One is
m ediated by opsonins while the other operates independent of opsonins.
In the opsonin-dependent system Legionella uptake is m ediated by the
com plem ent com ponent C3bi and the host cell com plem ent receptor
type 3 (CR3). C3bi is deposited on the major outer membrane protein
(MOMP) on the surface of Legionella and the MOMP/C3bi complex binds
to CR3 on human monocytes (12). The opsonin-independent uptake
mechanism occurs in an environment devoid of com plem ent or specific
antibody (75,76,152) and has been shown to produce a normal bacterial
replicative cycle in U-937 cells (75,152), as well as in MRC-5, HEp-2 and
Vero cells (134).
Following com plem ent-dependent adherence, Legionella organisms
are internalized by monocytes via coiling phagocytosis (83) and internalized
organisms are contained within banded enclosures (134). Shortly
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thereafter, phagosomes containing organisms becom e ribosome-lined
and are found in close association with mitochondria. The significance of
these observations is, as yet, unknown; however, these processes may be
important for the survival of this organism within host cells. Once the
bacterium is internalized survival depends on the inhibition o f phagosomelysosome fusion within infected mononuclear cells (82). The mechanism by
which Legionella inhibit phagosome-lysosome fusion is not understood.
Research in this area would add to our understanding of the molecular
events critical for Legionella survival in the inhospitable environment of the
m acrophage. Phagosome-lysosome fusion is one step in a series of normal
degradative process by which foreign material is destroyed within
phagocytes. The inhibition of these functions results in fulminant parasitism
of infected macrophages and is closely followed by unabated intracellular
replication of the organism.
Alternative mechanisms of intracellular survival are used by other
facultative intracellular bacterial pathogens (60,165). Some organisms
such as Listeria monocytogenes breakdown the structural integrity of the
phagosome and escape into the cytoplasm prior to phagosome-lysosome
fusion (125). Others, like Mycobacterium leprae, persist within phagosomes
that have fused with lysosomes and despite this bacteria actively multiply
within this hostile environment (125).
Following the course of unchecked intracellular multiplication,
legionellae escape from infected macrophages. The release of
legionellae from the confinements of the host cell phagosome is then
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followed closely by organism escape to the extracellular milieu. Release
facilitates continuation o f disease as progeny organisms initiate infection of
other cells in the surrounding tissues. Legionellae are released from
infected host cells by lysis (Table 1.4). The process by which Legionella
organisms escape the phagosome and the host cell cytoplasmic
membrane is as yet undefined; however, the major secretory protein of
Legionella, a zinc metalloprotease with powerful cytotoxic potential, may
play an important role in this process.
The terminal line of constitutive defense in the lung is the alveolar
m acrophage and this is important for the destruction of foreign material
arriving in the lower respiratory tract. However, it is this cell which
Legionella preferentially infects; the very cell designed to eradicate it. The
cell-m ediated branch of the immune response is critical to recovery from
Legionnaires' disease. However, it is unclear whether humoral defenses
also play a part in recovery or immunity to infection (89,91). Opsonization
of Legionella with specific antibody enhances the adherence of this
organism to mouse macrophages, as well as to U-937 cells and it has been
suggested that without specific antibody complement may not enhance
the uptake of L pneumophila (91).
Iron is a requirement for the growth of most bacteria including
pathogens whose virulence is frequently enhanced by iron (66). L.
pneumophila has a strict requirement for high concentrations of iron to fuel
m etabolic activities. During infection of monocytes, L pneumophila
sequesters iron from the intermediary labile iron pools of the host cell.
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However, the mechanism legionellae use to obtain the iron necessary for
continuation of disease is not known. This iron pool is formed from irontransferrin and iron-lactoferrin via transferrin and lactoferrin receptors
respectively. Furthermore, iron is also available in the protein-bound form,
ferritin. Intracellular replication of legionellae can be inhibited by treating
monocytes with substances which decrease iron availability (22,23,24).
These known inhibitory agents include iron chelators such as apolactoferrin
and deferoxamine, agents which interrupt the evolution of iron from irontransferrin like ammonium chloride and chloroquine as well as molecules
that normally down-regulate transferrin receptors such as gamma
interferon (IFN-y) (22,23).
L. pneumophila is incapable of intracellular replication within PMNLs
whether or not these cells are in the presence of IFN-y, specific antibody or
complement. Moreover, PMNLs are not appreciably involved in the killing
of legionellae, yet they may play a role in determining the eventual
outcom e of infection. Indeed, depletion o f PMNL from the lungs of guinea
pigs was shown to be detrimental to recovery (62). A mechanism that may
explain the role of PMNLs during infection suggests a cooperative effect of
PMNLs with monocytes or macrophages. At the site of infection PMNLs
release large quantities of apolactoferrin that could be taken-up by
infected cells. The concom itant reduction of iron availability following the
uptake of this chelator would effect the reduction of intracellular
replication of L. pneumophila. As cell parasitism occurs with or without
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PMNLs, the inhibitory mechanism suggested would be only partially
effective for control. Augmentation or enhancem ent of this
bacteriostatic-type system may help to control infection and requires
further investigations.
L pneumophila has been shown to produce various toxins including
legiolysin (a hemolysin), endotoxin (LPS) and a tissue destructive protease
(13,38). However, little is known about the role these molecules play in the
developm ent o f disease. Cytopathology of destroyed lung tissues
previously infected by L. pneumophila is suggestive o f cytotoxic activities
(10, 14,183) (Table 1.5).
The protease of L. pneumophila, the major secretory protein, has
been described as one of the more important molecules produced by the
organism during infection. During the initial identification studies following
the Philadelphia epidemic, a toxic etiology was suggested as an
explanation of this outbreak (68). The organism produces a protease and
this molecule was determined to possess both caseinase and gelatinase
activities. Further investigations have identified the Legionella protease as
a zinc metalloprotease with a molecular mass of 38,000 to 40,000 (38,140).
Hemolytic, cytotoxic and tissue destructive properties have been
demonstrated for this molecule. Whether the protease is necessary as an
im portant mediator of cell parasitism leading to establishment o f infection
or as a molecule essential for organism escape from infected cells is not
known. Studies have indicated that the protease is produced primarily
while the bacterium is within host cells and little is secreted when the
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Table 1.5: Structural Virulence Factors of Legionella pneumophilae

Structure

Characteristics

Fimbriae

Putative adhesin

Flagella

Common Antigen for
Serogroups 1-3
Putative Adhesin

Lipopoly saccharide

Activates Complement
Cascade
Potent Stimulator of Humoral
Response
Weak Endotoxin
Putative Adhesin

Major Outer Membrane Protein

Genus Specific Epitope
Species Specific Epitope
C3 A cceptor Molecule
Putative Adhesin

Legiolysin

Hemolytic properties

Major Cytoplasmic Membrane Protein

Heat Shock Protein (Hsp60/65)
Potent Stimulator of Humoral
Response
Genus Specific Epitope

M acrophage infectivity Potentiator

Potentiates infection of
mononuclear phagocytes
Inhibits activity of host cell
Protein Kinase C

Major Secretory Protein

Zinc Metalloprotease
Cytotoxic for CHO cells
Produced intracellularty within
monocytes

a Observations primarily associated with human disease
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bacterium is in the extracellular menstruum. However, strictly controlled
physiologic in vitro studies have not been done to investigate these
processes.
In addition to cytotoxic activity, hemolytic activity has been
described for L. pneumophila (14.69,98,188). Legiolysin, the hemolysin of
L. pneumophila is a 39-kDa protein which has been studied and has been
cloned into E. coli. This hemolysin also confers the additional phenotypic
characteristics of brown pigment formation on tyrosine containing media,
as well as mediating colonial auto-fluorescence in longwave UV light (186).
Despite cloning of the gene and partial characterization of this molecule,
little is known about the role this structure plays in the pathogenesis of
Legionella infections.
As is the case for the majority of gram -negative bacterial pathogens,
L. pneumophila produces lipopolysaccharide (LPS). Initial investigations
have provided contradictory evidence for the role of L. pneumophila LPS
in virulence. LPS can activate the classical com plem ent cascade (121);
however, the precise nature of this process remains obscure. Legionella
LPS is also the major immunogenic structure on the surface of this
bacterium (71). Moreover, LPS can induce the production of immune
modulators in mouse spleen cultures including interleukin-1 and interleukin2, IFN~y and tumor necrosis factor (16,17).
Other Legionella proteins have been shown to play a t least some
role in the pathogenesis of Legionnaires' disease. The m acrophage
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infectivity protein (MIP) was shown to be important for uptake of L.
pneumopNIa by macrophages (30.31). This molecule is a 24-kDa
molecular mass protein the gene for which has been cloned into E. coli and
sequenced (29.51,52). The MIP protein was shown to be conserved
across the genus; however, there are notable variations in the migration
pattern o f the MIP protein between species (31).

1.4.2 Environmental Aspects
The ability of L. pneumophila to replicate within phagocytic
freshwater am oebae was initially reported by Rowbotham (147). In
subsequent years, several reports have confirmed that legionellae can
multiply within a variety of protozoa including Acanthamoeba
castellanii.Naeglaria fowleri, Hartmanneiia vermiformis and the ciliated
protozoa Tetrahymena pyriformis (59 122,130). Several studies have
identified environmental sources in which L pneumophila organisms
survived and have been shown to be responsible for several outbreaks of
legionellosis (8,58). In some cases, the protozoa isolated from these
reservoirs have been shown to support the growth of Legionella in vitro
(58). To date, there is no evidence to support the multiplication of
Legionella organisms in an environment devoid of protozoa or host cells.
The mechanism by which Legionella parasitize protozoa in the
environment has yet to be defined. Furthermore, the characterization of a
receptor on the surface of the am oebae that is responsible for the
attachm ent of L. pneumophila has not been identified. Several research
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groups have suggested that human infection by legionellae is a
coincidental event in that Legionella may recognize a highly conserved
structure on the surface o f the alveolar m acrophage which structurally
mimics that on am oebae. A valid case can be made for coincidental
human infection since humans form a dead-end host with no known
mechanism for human to human transmission. This putative conserved
surface structure located on am oebae and lung alveolar macrophages
may allow for attachm ent and facilitate uptake, or allow for intracellular
replication of L. pneumophila within these cells.
The mechanism of adherence for L. pneumophila to protozoa has
yet to be identified; however, this organism has been shown to attach to
human monocytes via tw o different molecular mechanisms, one of which
requires complement, while the other process occurs in an opsoninindependent fashion (76,88). In the natural aquatic environment,
com plem ent-m ediated uptake is an unlikely process, but rather this
mechanism would involve an 'a d h e sin '-'re ce p to r' complex arrangement
between L pneumophila and amoebae. Thus it is believed that Legionella
may parasitize the alveolar m acrophage at the earliest stage of organism
recognition, in a manner similar to that by which these organisms parasitize
fresh water am oebae.

1.5 Disease
1.5.1 Epidemiology
Legionellae are not primary pathogens for humans, but rather are
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opportunists which cause severe disease. For infection to occur, L.
pneumophila must be presented to the host in aerosol form and the
inhalation of small water droplets is necessary for colonization to occur
(183). Confirmed cases o f legionellosis must be reported to state health
authorities and to the C.D.C. to facilitate national surveillance o f this
infectious disease. There are approximately 1300 cases of legionellosis
annually and the incidence has shown a general rising trend since its first
appearance (Fig. 1.1 and Fig 1.2). It has been suggested that the 1300
annual cases is a conservative or much underestimated figure and that
there may be up to 100,000 cases of legionellosis per year (85). L
pneumophila serogroup 1 is responsible for 85% of all reported cases of
community-acquired legionellosis while other serogroups of L. pneumophila
and L. macdadeii make-up the remainder.
Legionella spp. have been isolated from a wide variety of fresh
water environments. The organisms is ubiquitous in lakes, ponds, streams,
thermal lagoons, muds, sediments and potable water supplies (67,126). In
addition, legionellae have been isolated from shower heads, whirlpools,
spas, respiratory therapy equipment (6,126) and supermarket vegetable
water misting systems (108). Legionella have also been found to
contam inate potting soil mixes (168).
In the environment, phagocytic am oebae are believed to play a
major role in the survival and persistence of Legionella and, prior to
am plification of this organism followed by colonization of water supplies
leading to outbreaks of disease is believed to be due to these protozoa
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Figure 1.1: Total number of cases of legionellosis as reported by the Center
for Disease Control and Prevention (CDC) Atlanta GA.. Adapted from
C.D.C. Morbidity and Mortality Weekly Reports, Summary of Notifiable
Diseases, United States 1992.
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Figure 1.2: Total number of cases of legionellosis per 100,000 people as
reported by the Center for Disease Control and Prevention (CDC) Atlanta
GA.. Adapted from C.D.C. Morbidity and Mortality Weekly Reports,
Summary o f Notifiable Diseases, United States 1992.
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Figure 1.3: Total number o f cases of legionellosis per 100.000 as reported
by each state as docum ented by the Center for Disease Control and
Prevention (CDC) Atlanta GA.. Adapted from C.D.C. Morbidity and
Mortality Weekly Reports, Summary of Notifiable Diseases, United States
1992.
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(8,147). The establishment of a cell model for investigating Legionella
interactions with protozoa is necessary for understanding the normal
events of Legionella persistence in the environment.
Inhalation of contam inated aerosolized water droplets is the normal
route of infection; however, use of contam inated water on bandage
dressings as a follow-up to invasive surgical procedures has lead to the
developm ent of systemic Legionnaires' disease (105). The normal
operation of evaporative cooling systems generates and disseminates
aerosols. Those small water droplets, approximately 5-15 nm in diameter,
remain airborne and, when inhaled, are not entraped by the constitutive
defenses of the upper respiratory tract. On the other hand, they are large
enough to contain Legionella organisms. On descending into the lower
respiratory tra ct to water droplets impinge on the walls o f the alveolar sacs
where organisms are taken-up by alveolar macrophages. These cells are
not readily able to destroy Legionella organisms without prior sensitization.
The result of this phenomenon is development of severe lobar pneumonia
especially in the immunocompromised.
Community-wide outbreaks are uncommon; however when they do
occur these outbreaks are usually spectacular in nature and are most
frequently attributed to evaporative condensers or cooling towers which
harbor the organism (68,77,173). More frequently, nosocomial and
sporadic cases contribute to the bulk of yearly reported incidence of
legionellosis.
Men are more frequently infected by L. pneumophila than women
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and infection in children is rare. Imunosuppressed patients are most
susceptible to infection while other a t risk groups include patients with high
alcohol intake, heavy smokers, people recovering from invasive surgical
procedures and others suffering from underlying conditions or infections
such as lymphomas, leukemia and AIDS (7,105).

1.5.2 Clinical Presentation
The incubation period for Legionnaires' disease is 2-10 days (68) and
the prodromal symptoms include fever, chills, malaise, anorexia and
weakness, and occasionally headache and myalgia (68). As infection
proceeds, the acute onset of headache and fever occurs. Pulmonary
disease predominates and within 3-5 days from the onset of symptoms,
patients will likely require hospitalization and intensive care. The cough
associated with early-stage Legionella infection is usually nonproductive;
however, as the disease proceeds, the cough may becom e productive
with a rust colored (blood tinged) or non-purulent sputum. Later in
infection, lung function is compromised, purulent sputum is produced and
patients undergo major systematic changes with abnormal liver function
tests, blood gas and electrolyte imbalances and signs of confusion,
respiratory collapse and cardiac failure. Patients require intubation and
aggressive intervention-type therapy along with appropriate antibiotics.
Despite these procedures, patients often fail to respond.
Radiological examination of the lungs of infected individuals shows a
picture consistent with lobar pneumonia (184). Patchy unilateral infiltrates
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are noted a t the initial stages of disease, while bilateral infiltrates are noted
in up to two-thirds of patients (54,98). Extension of these infiltrates
continues with subsequent consolidation evident in one or more lobes of
the lung. The infiltrates can persist for up to several months after patient
recovery. Nodular lesions may be present and can resemble the lesions of
some fungal infections (33). Plural effusions are common but abscesses
are rarely seen by radiologic examination. This is in contrast to the
pathologic study o f tissue specimens in that the lungs o f fatal cases of
Legionnaires' disease frequently show abscess formation (184).
Pathologic examination of lung specimens indicates that
Legionnaires' disease is a multifocal pneumonia with coalescence in the
late stages o f disease (184). The distal airways including the alveoli and
terminal bronchioles are primarily affected while the proximal bronchioles
and bronchi are not usually involved. Lesions induced by this organism are
distinct and are similar for all pathogenic species of Legionella (184);
however, in some cases, these lesions are difficult to distinguish from
classical pneum ococcal pneumonia. Lung exudates are fibrinous and
primarily contain neutrophils and macrophages; however, given this
exudate developm ent during infection the lack of sputum production is not
understood.
Extrapulmonary involvement can occur during severe cases of
disease, but these events are more common for L. pneumophila-induced
disease than for disease caused by other members of the genus (3).
Bacteremia has been docum ented (47) and extrapulmonary infections
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include cerebral microglial granuloma, cutaneous and hepatic abscess
formation, endocarditis, pericarditis and pyelonephritis (3,31,47,63,112,
113,146). Intra-alveolar fibrosis is common and permanent sequelae
including decreased pulmonary function are common (27,102).
it is unclear whether resistance occurs in people who have
previously been infected with the Legionnaires' disease. Studies with
guinea pigs have indicated that protective immunity is conferred on
animals which were challenged by intraperitoneal injection o f killed
Legionella antigens, but similar studies using aerosol challenge to guinea
pigs did not prevent infection (51).

1.5.3 Diagnosis
By comparison with those more frequent causes of pneumonia such
as (Streptococcus pneumoniae and Hemophilus influenzae) the incidence
o f Legionnaires' disease is relatively low. However, the reported incidence
of Legionella-induced pneumonia from multi-center studies of pneumonic
illness (100 or more cases of pneumonia) indicates a relatively high
percentage of these cases are of Legionella origin (55,184). Difficulties
associated with the clinical diagnosis of L. pneumophila infections due to
the similarity of symptoms and radiographic analysis of disease induced by
Legionella and other microorganisms and viruses are common. To add to
the difficulties in identifying Legionella-induced pneumonia, these
organisms are intracellular pathogens and as such do not stain well using
conventional grams stain procedures. Therefore, other identification
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criteria including antigen or nucleic acid detection, and serological
techniques are implemented to augment conventional laboratory culture
when Legionella-induced pneumonia is suspected.
However, the gold standard for the diagnosis o f L. pneumophila is
cultivation (42). The legionellae are nutritionally fastidious and will not grow
on conventional laboratory media. BCYE-a is the medium of choice for
growth and identification of this pathogen. The sensitivity of cultivation
ranges from 50-80%; It is, however, 100% specific (42, 185). L. pneumophila
colonies possess a characteristic opalescent, cut glass appearance with
smooth entire edges and these colonies, which present in a variety of sizes,
appear 3-5 days after inoculation of clinical material onto this media.
Several versions of BCYE-a have been developed to make this medium
selective for legionellae from both clinical and environmental samples.
Two semi-selective media have been created: the first, BMPA m edia,
includes the antimicrobials cefamandole, polymyxin B and anisomycin (44)
while the Wadowski-Yee formulation includes glycine a potent inhibitor of
gram negative bacteria together with cefamandole, polymyxin B and
anisomycin (179). These remove contaminants which would otherwise,
quickly outgrow the legionellae. It has been suggested that all three media
formulations should be used for the isolation of legionellae as some species,
especially L. micdadei. are inhibited by the antibiotics present in these two
selective media formulations. In addition to bacteriologic cultivation,
laboratory identification frequently includes the use o f direct
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immunofluorescence, nucleic acid probes, radioimmunoassay (RIA) and
polymerase chain reaction (PCR) technology (44,79,108,168,174).
Other additions to the basic BCYE-a media formulation include
bromocresol purple and bromothymol blue, the presence of which
enhance the recognition of some Legionella species, but affords no
advantage or a disadvantage for organism growth. Although albumin
enhances the recovery of L bazemanii and L m icdadei from tissue
samples It does not affect the recovery of L. pneumophila from specimens
(123).

1,5.4 Antimicrobial Chemotherapy
Without an effective vaccine for the prevention of legionellosis a
com bination of aggressive antibiotic and clinical intervention is required for
the successful treatm ent of infected patients. Following the Philadelphia
outbreak, epidem iologic studies indicated that those who received
erythromycin therapy fared better than those individuals who had received
other antibiotics (68). Few antimicrobial agents have proven effective for
the treatm ent of Legionella pneumonia. On the other hand, in vitro studies
have demonstrated that legionellae are sensitive to an extensive array of
antibiotics (151,177, 178). The macrolides have proven most efficacious
for the treatm ent of Legionnaires' disease. Although erythromycin is the
drug of choice for the therapy of legionellosis, this antibiotic is not well
tolerated by some people and causes peripheral phlebitis and intestinal
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upset. Other mocrolides and alternative antibiotics may be used while
others are continuously sought and tested for clinical use (45.46,78,151).
A major criterion for the efficacy of any antimicrobial agent in the
treatm ent of Legionnaires' disease is membrane transportability. As
legionellae are facultative intracellular pathogens antibiotics must enter
the host cell for effective activity. Erythromycin penetrates cell
membranes well and for this reason it Is the drug of choice of
Legionnaires' disease. In severe, potentially life-threatening cases, rifampin
and other antibiotics are often used in combination with erythromycin (9).
Several studies have suggested that other antibiotics may be
effective for the control of this disease (45,177). One such group of
promising antimicrobials are the fluoro-substituted quinalones. Of this
group, ciprofloxacin was shown to be particularly effective for treatm ent
of Legionnaires' disease both in vitro, as well as, in clinical trials (129,177).
Tzianabos and Rodgers (177) extensively studied the in vitro effects and
demonstrated that ciprofloxicin, like erythromycin, was effective against
intracellular organisms and hence Legionnaires' disease. In subsequent
studies, clinical trials have shown ciprofloxicin to be effective for the
treatm ent of human legionellosis.

1.6 Comment
During the past 18 years, vast amounts of information have amassed
concerning many of the major physiologic and pathogenic facets o f L.
pneumophila. In addition, procedures necessary for the diagnosis and
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identification of the organism leading to the establishment of legionellosis
have been forthcoming. However, Legionella-induced pneumonia is still a
major cause of respiratory illness. This organism will continue to be of
clinical importance until an effective vaccine has been developed. It is
unlikely, however, that a vaccine will be available in the very near future
since many of the immunological processes involved in the development
or recovery from Legionella-Induced pneumonia are still unclear. To help
control legionellosis work must continue in the area of host-cell interaction,
both in the environment in terms of Legionella-protozoa interactions, as well
as, in the clinically significant areas of organism-macrophage interaction
and intracellular survival. Indeed, given the intracellular nature of
Legionella, a vaccine which prevents the intracellularization of the
organism should interfere with the prosecution of the disease within the
lungs. The development of such a vaccine should prove an effective and
viable alternative to antimicrobial chemotherapy for the prevention and
control of Legionnaires' disease.
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SECTION II

CHARACTERIZATION OF
INTRACELLULAR REPUCATION FOLLOWING OPSONIN-INDEPENDENT
ADHERENCE OF LEGIONELLA PNEUMOPHILA TO U-937 CELLS.

(The work outlined in this section has been published in the following articles:
Rodgers, F. G., and F. C. Gibson. 1993. Opsonin-independent adherence
and intracellular development of Legionella pneumopNIa within Li937 cells. Can. J. Microbiol. 39: 718-722.
Gibson, F. C., and F. G. Rodgers. 1993. Ultrastructure of the Adherence
and Intracellular Replication of Legionella pneumophila in
M acrophage-like U937 cells. In: Barbaree, Breiman, and Dufour:
Legionella: Current Status and Emerging Perspectives. ASM.
Washington D.C. pp. 115-118.)

2.1 Abstract
Legionella pneumophila is an opportunistic bacterial pathogen that
infects alveolar macrophages in the human lung during the initial stages of
disease. To define the interactions of this organism with human alveolar
m acrophages requires the use o f cell models to mimic alveolar
macrophages; cells which are difficult to obtain in a healthy state. As a
consequence, many cell types have been used to simulate the interaction
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of L pneumophila with alveolar macrophages. The U-937 cell, a
transformed human macrophage-like cell line, has been shown to support
the growth of L. pneumophila. In some ways these cells are similar to
alveolar macrophages in that they express com plem ent and Fc receptors
and in this respect they may be more representative o f macrophages for
the study of Legionella attachm ent and growth than many other cell
models thus far described. Observations to elucidate the initial interactions
of this pathogen with human cells identified a complem ent-dependent
system for describing Legionella attachm ent to monocytes. It has been
proposed that an alternative attachm ent mechanism occurs for L.
pneumophila and that this binding process is effected independent of
serum factor influences. The growth kinetics and stages of cell infection
involving this opsonin-independent system as verified by electron
microscopy have been characterized and are similar to those process
described following com plement-mediated attachm ent. Cellular and
ultrastructural studies indicated that legionellae bound to U-937 cells within
1 h and replicated rapidly over a 30 h period within ribosome-lined
phagosomes in association with mitochondria and endoplasmic reticulum.
Release of organisms from infected cells occurred by lysis which
com m enced approximately 30 h after infection. This work establishes the
U-937 cell as an effective model for understanding Legionella alveolar
m acrophage interactions.
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2.2 Introduction

Legionella pneumopNIa is an intracellular bacterial pathogen that is
the etiologic agent of a severe form of life-threatening lobar pneumonia.
Approximately six months after the Philadelphia epidemic McDade e t al.
(155) demonstrated that the causative agent of this outbreak was a
previously unidentified bacterium that was found in biopsied lung tissue by
light microscopy. Subsequently, Rodgers e t al. (146) demonstrated by
electron microscopy that L. pneumophila functioned as a facultative
intracellular pathogen replicating inside host lung cells. The intracellular
nature o f the Legionnaires' disease bacterium is critical for the
establishment of disease in humans. Furthermore, it aids organism survival
by facilitating the evasion of the immune defence mechanisms of the host.
Since the early 1980's studies have endeavored to elucidate the infectious
process o f L pneumophila within host cells (75,87, 111,132, 136, 152). As a
number o f studies have shown, defining infection o f host a t the cellular
level as well as understanding the interaction between the organism and
the immune system of the host have proved problematic. Although, the
general stages of Legionella infection, at the cellular and systemic levels,
have been identified and a clearer picture of the pathogenesis of
Legionnaires' disease has evolved, much remains to be elucidated on the
nature and role o f bacterial virulence factors as well as host-mediated
responses.
Legionellae are environmental organisms and are ubiquitous in
freshwater habitats. While in these aquatic environments, L. pneumophila
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has a close relationship with phagocytic amoebae. Legionellae parasitize
these cells and the resultant intracellular replication and release of
bacterial progeny perpetuates these organisms in the aquatic
environment. Preliminary investigations outlining Legionello-am oeba cell
interactions were described in 1980 (146). Since then several studies have
identified many host cells that support the intracellular replication of L
pneumophila (57,120,128). It is commonly believed that human disease is
coincidental and offers no ecological advantage to the organism. These
bacteria when presented in aerosolized form are taken up by the host and
preferentially infect alveolar macrophages which, it is postulated, are
infected in a fashion similar to am oebae in the environment. Several useful
models for describing L. pneumophila interaction with protozoa have been
reported (59,131). The stages o f protozoal infection are very similar to
those observed with human cells and include such important processes as
ribosome-lining of phagosomes containing organisms, as well as similar
intracellular replication kinetics ( 120).
In human disease, the alveolar macrophage is the target cell for
Legionella infection. Due to the inaccessibility and unavailability of human
alveolar macrophages, a suitable cell model simulating alveolar
macrophages was required. A wide variety of cells have been used to
study Legionella/host cell interactions and the ultrastructural developm ent
of intracellular Legionella and these include MRC-5, Vero, HEp-2 , HL-60 and
U-937 as well as primary explants of human peripheral blood monocytes
and human, guinea pig and simian alveolar macrophages (50,75,99,111,
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136,152). None of these cells is ideal in that each only approximates some
of the normal activities of human alveolar macrophages in vivo.
Initial work centered on the role o f the immune response of the host
to this pathogen and as a consequence, a complement-mediated
receptor binding mechanism was outlined (12,128,188). Recently, a novel
attachm ent process for this organism has been suggested that occurs
independent of serum influences (75,76,152). Host cell recognition is
followed by attachm ent of the bacteria to surfaces that possess
appropriate receptors. Direct binding of bacteria to host cells have been
described for group B streptococci and Yersinia pseudotuberculosis (4,92,
93). Furthermore, recent work studying uptake of bacteria by phagocytes
demonstrated that the mode of attachm ent (com plem ent/antibody or
direct binding) affected the subsequent intracellular fate of the organisms
(187). It is possible that opsonin-independent binding mechanisms are
necessary for intracellular infection to develop and that this may play an
important role in the maintenance of disease.

2.3 Materials and Methods
2.3.1 Organism Cultivation: L pneumophila serogroup 1. strain Nottingham
7 is a highly virulent clinical isolate from a fatal case of Legionnaires'
disease. Initially the organism was isolated from sputum on low sodium,
enriched, blood agar. Colonies were sub-cultured once onto buffered
charcoal yeast extract agar supplemented with a-ketoglutarate (BCYE-a)
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(Difco, Detroit, Ml) and stored as stock cultures frozen a t -70°C in 1% serum
sorbitol (Appendix 1). Thawed aliquots were passaged once for 72 h on
BCYE-a a t 37°C in a humid atmosphere with added CO 2 prior to
experiments. Colonies were harvested and resuspended in buffered yeast
extract broth containing a-ketoglutarate (BYE-a) to give 58 Klett units
(equivalent to 1-2x108 colony forming units/ml). Tubes containing 5 ml
sterile BYE-a were inoculated with 100 nl of this 58 Klett unit suspension and
were grow for 24 h at 37°C with vigorous shaking. Following growth, 1ml
samples were placed into eppendorf tubes and centrifuged a t 8 XXX) x g
for 15 min in a Beckman microfuge 12. Supemates were drawn off and
p>ellets were resuspended in 1 ml sterile Hank's balanced salt solution
(HBSS). This process was repeated 3 times and the organism containing
samples were resuspended with fresh HBSS prior to infection assays.
Periodic assessment of Legionella virulence using the fertile hens'
egg assay (Fig. 2.1) was conducted during the course of these studies to
ensure that organism virulence was maintained (176).

2.3.2 U-937 cell Cultivation: U-937 cells were grown in RPMI-1640 cell
culture media (Sigma, St. Louis, MO.) supplemented with 10% fetal bovine
serum (FBS) in T-75 cm 2 cell culture flasks (Costar, Cambridge, MA.) a t 37°C
with 5% CO 2. Cells were grown to a density of 1-2 x 106 cells/ml, harvested
by centrifugation at 250 x g for 10 min in 50 ml conical tubes (VWR
Scientific). Supernatant fluids were removed and cells were resuspended
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Figure 2.1: Diagrammatic representation illustrating the
compartmentalization of the fertile hens' egg. The yolk sac route of
inoculation was used to monitor virulence of L pneumophila in this model
(176).
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to give 5 x 105 viable cells/ml in 20 ml of fresh RPMI-1640 with 10% FBS.
Differentiation of the U-937 cell to the macrophage-like status was done by
adding 25 ^1 of a 10-5 M solution of phorbol myristate acetate (PMA) to
these cultures for 24 h. Adherent cells were washed 3 times with HBSS,
physically removed from the culture flasks by gentle scraping with a silicon
rubber-coated glass rod and harvested by centrifugation a t 250 x g for 15
min. Collected cells were resuspended in fresh RPMI-1640 with serum a t 5 x
105 cells/ml and aliquoted into either T-75 cm2 flasks (20 ml) for thin section
transmission electron microscopy (TEM), 6 well plates (3 ml) each containing
a 22 mrr>2 glass coverslip for scanning electron microscopy (SEM) or 24 well
plates (1ml) for viable bacterial cell colony (VBCC) counts studies cells
were allowed to readhere in culture vessels for 24 h.

2.3.3 Infection Assay
U-937 cells were inoculated with L, pneumophila at a multiplicity of
infection (MOD of 100 bacteria per host cell a t 37°C for 1 h in fresh HBSS
within an atmosphere containing 5% CO 2. After the infection period
monolayers were washed 3 times with HBSS. At this stage, fresh RPMI-1640
medium with serum was added to each sample. Samples were collected
at 1,6,12,24,48 and 72 h post infection. For TEM and SEM, infected
monolayers were washed 3 times with cacodylate buffer containing lOmM
MgSCXr pH 7.4 (CB), fixed for 18 h in 2% (v/v) glutaraldehyde (Electron
Microscopy Science, Ft. Washington, PA) in CB and washed 10 times with
CB in situ.
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2.3.4 Viable Bacterial Cell Colony Count: In conjunction with electron
microscopic investigations o f the attachm ent, intracellular replication and
release events of L. pneumopNIa infection of U-937 cells, VBCC counts
studies were performed to assess the rate of cell infection and intracellular
replication of this organism. Following the 1 h infection of U-937 cells,
supernotes were removed and each well was washed three times with
HBSS to remove unbound bacteria. The three washings along with the
supernotes were collected and pooled for each sample time. Serial 10fold dilutions of these pooled samples were made in 1% (w /v) peptone and
duplicate samples of 25 ^1 were plated on BCYE-a agar for colony counting
evaluations.
At each of the prescribed tim e intervals, cultures were assessed for
both intracellular as well as extracellular bacteria. Following collection of
supernatant fluids together with each of the 3 x 1 ml HBSS washings, the
cells in each well were lysed by adding 1 ml sterile Milli-Q water for 30 min.
The cells were then physically disrupted with vigorous aspiration and
expulsion using a sterile pasteur pipette. For each time interval, a 100 pJ
aliquot was removed from each of the supernatant fluids plus wash
samples as well as each lysate. These samples were each 10-fold serially
diluted in 1% (w/v) peptone and duplicate 25 nl samples were plated on
BCYE-a agar for the enumeration of intracellular and released legionellae.

2.3.5 Transmission Electron Microscopy: For TEM, glutaraldehyde-fixed U-
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937 cells in CB were physically removed from the T-75 cm2 culture flasks
with the aid of a silicone rubber-coated glass rod and harvested by
centrifugation a t 200 x g in a Beckman model TJ-6 centrifuge. Samples
were pre-em bedded in molten 1% (w /v) Noble agar maintained at 55°C.
The agar em bedded specimens were allowed to set at room temperature,
were cut into 1 mm3 blocks and post-fixed in 1% (w/v) osmium tetroxide
(OSO 4) in CB for 24 h. Samples were then dehydrated in an ethanol series in

CB consisting of 50%, 70%, 75%, 90%. and 95% for 5 min each and then into
tw o changes of absolute ethanol for 10 min each. Samples were
equilibrated in tw o changes, 10 min in propylene oxide (epoxy propane)
and embedded in an epon-aryldite resin mixture (Appendix 2). At no time
were samples allowed to dry. After polymerization at 60°C for 24 h, blocks
were sectioned on a LKB ultramicrotome III using a diamond knife. Sections
o f 60-90 nm thickness were collected onto 400 mesh copper grids
(Electron Microscopy Science), were stained with 1% (w /v) uranyl acetate
for 1 min. and 0.4% (w/v) lead citrate for 30 sec. and examined in a Hitachi
H-600 scanning-transmission electron microscope at 75 kV in the
transmission mode.

2.3.6 Scanning Electron Microscopy: For SEM, glutaraldehyde-fixed
samples were washed thoroughly with PBS at pH 7.2 and dehydrated in a
graded ethanol series to absolute ethanol. Specimens were fully dried
from hexamethyldisalizane (EMS, Fort Washington, PA) in air. Monolayers on
coverslips thus dried were sputter coated with 20 nm gold-palladium in a
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Hummer V sputter coater with a specimen to target distance of 5 cm for 4
min a t 15 mA and observed in an AMR 1000 scanning electron microscope
a t6 0 kV.

2.4 Results
The virulence of the stock cultures of this strain remained unchanged
from previous studies (176). Adherence of L. pneumophila to U-937 cells in
the absence of opsonins was observed within the 1 h incubation period
(Fig. 2.2). By comparison with normal control (uninoculated) U-937 cells (Fig.
2.3), analysis of the 1 h post-inoculation specimens by TEM showed that
wash-resistant attachm ent involved apposition of L pneumophila
membrane blebs and host cell surface membranes (Fig 2.4). SEM
observations of similar monolayers showed numerous legionellae adherent
to U-937 cells. In addition, SEM data suggested that little host cell change
occurred following these initial adherence steps of virulent bacteria to host
cells (Fig. 2.5). VBCC counts data indicated that approximately 1x10*
bacteria had attached to 5 x 105 U-937 cells. From this it was clear that
approximately 2 bacteria had bound to each U-937 cell in the monolayers
and this constituted 2% of the initial inoculum (Fig. 2.2). Neither coiling
phagocytosis (83) nor the presence o f banded enclosures (Oldham and
Rodgers) previously reported for human monocytes and other cells were
observed; however, these differences may have reflected the absence of
opsonic components in the adherence medium in the present study.
Rapid intracellular bacterial multiplication was observed (Fig 2.2).
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Figure 2.2: Attachment and intracellular replication of L pneumophila
N7 in U-937 cells measured by VBCC counts. U-937 cells at 5x10
cells/ml were infected with a MOI Of 100 L. pneumophila and washed 1
h after infection. Intracellular replication ( O - O ancl Cleese ( # —0 )
of legionellae. Assays were the average of three trials and bars
represent standard error.
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Control U-937 cells SEM and TEM

Plate 2.3: Untreated U-937 cells observed by transmission electron
microscopy (A) and scanning electron microscopy (B). Magnification A =
x 17,(XX); B = x 3000. Bars: A = 2 jim and B = 10 jim.
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1 h U-937 Cells TEM with inset high magnification

Plate 2.4: L. pneumophila bound to a U-937 cell 1 hr after infection. Inset:
higher magnification of host cell-bacterium interaction. Note electron
lucent zone between organism and cell. Magnifications A = x 17,000; B =
x 60,000. Bars: A = 2 pm and B = 300 nm.
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1 h U-937 cells SEM

Plate 2.5: L pneumophila bound to U-937 cell at 1 hr after infection by SEM.
Note several bacteria bound to the surface of the host cell. Magnification
= x 5000. Bar represents 5 jim.
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Plate 2.6: TEM (A) and SEM (B) of L pneumophila 12 hr after infection of LI937 cells. Organisms are contained within loose phagosomes which are
ribosome-lined. Effects of infection on host cells include blunting and a
decrease in the number of microvilli on the surface o f U-937 cells.
Magnification: A = x 20,000; B = x 3000. Bars: A = 3 nm and B = 10 pm.

24 h U-937 cells SEM and TEM

Plate 2.7: TEM (A) and SEM (B) of L pneumophila 24 hr after infection of LI937 cells. TEM of organism infected U-937 cell. Note fulminant infection of
cell as well as the release of organisms from the phagosome. B. SEM of
infected cells. Cells are rounded and show a decrease in the number of
microvilli which show marked blunting. Magnification: A = x 13,600; B =
x 3000. Bars: A = 2 |im and B = 10 nm.
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46 h U-937 cells SEM and TEM

Plate 2.8: TEM (A) and SEM (B) of L. pneumophila 48 hr after infection of LI937 cells. TEM o f organism infected U-937 cell. Note bacteria no longer
confined to phagosomes and some bacteria can be seen in the
extracellular milieu. B. SEM shows almost com plete loss of microvilli.
Magnification: A = x 25,500; B = x 3000. Bars: A = 2 |im and B = 10 p.m.
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72 h U-937 cells SEM and TEM

Plate 2.9: TEM (A) and SEM (B) of L pneumophila 72 hr after infection of LI937 cells. Host cells are seen a t the terminal stages o f infection. Cell lysis

and lack o f bacteria within cells are noted in both TEM and SEM
presentations. Magnification: A = x 13,600; B = x 2000. Bars:
B = 10 |im.
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Intracellular bacterial replication, which occurred by pinching binary fission,
was evident by 12 h post-infection o f cell monolayers (Fig 2.6). Legionella
replication occurred initially in tight, ribosomes lined vacuoles and later
these phagosomes were much distended. Host cells at this time possessed
fewer microvilli at the surfaces. By 24 h post infection, intracellular L.
pneumophila were confined to loose vacuoles within the U-937 cell (Fig.
2.7). At this stage of the infectious process, cytoplasmic clearing was
evident and extensive intracellular dam age was also noted. Continued
loss and blunting of microvilli were apparent as the infectious process
continued. Gross morphologic surface changes were evident by 48 h
post-infection and these included cell lysis with a concom itant increase in
cellular debris as was evident by TEM and SEM (Rg 2.8). Although bacteria
were observed within cells a t 48 h post-infection they were present within
disrupted vacuoles. At this stage of the infectious process the integrity of
the plasma membrane was breached in numerous cells and released
bacteria predominated. By 72 h cellular infection and disruption was
com plete with >95% of the U-937 cells detached and lysed (Fig. 2.9). VBCC
counts of washed samples (extracellular organisms) and U-937 cell lysates
(intracellular organisms) showed maximal intracellular Legionella numbers
by 24 h of infection (Fig 2.2). As intracellular replication continued toward
the later stages of infection (72 h) an increase in the number of bacteria
was found in the extracellular milieu with a simultaneous decrease in the
number of intracellular organisms. In addition, L. pneumopNIa did not
replicate in either HBSS or RPMI-1640 with or without added FBS, whether
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previously conditioned with U-937 cells or not.

2.5 Discussion and Conclusions
Legionella pneumophila infections constitute a significant source of
m edical problems each year and an understanding of the infectious
process a t the cellular level is essential prior to the potential development
o f vaccines for the control of this pathogen. Investigations of biopsied
lung tissue strongly suggested the alveolar m acrophage as the most likely
candidate for the establishment of human disease (183). Although cell
models have been proposed to mimic human alveolar m acrophage
infection at the cellular level these cells are generally difficult to obtain.
Horwitz and Silverstein (88) initially described the interaction o f L.
pneumophila with human peripheral blood monocytes and since then
many cells have been shown to support intracellular replication of the
Legionnaires' disease bacterium (75, 111, 128,134,138,152). Although the
organism has been shown to replicate within epithelial, fibroblast and
mononuclear cells; they appear to be incapable of replication within
PMNLs (62, 88 , 134).
Several transformed cells have been proposed as potential cell models the
HL-60 cell which expresses polymorphonuclear leukocyte-like or
m acrophage-like characteristics and the U-937 cell, a histiocytic lymphoma
cell line which can express either monocyte or macrophage-like cell
surface markers (170). The U-937 cell has been used frequently as a model
cell to represent Legionella-host cell interactions (111, 138). Peariman e t al.
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(138) demonstrated that L pneumophila could infect the transformed
human histiocytic lymphoma cell line U-937. These studies suggested that
U-937 cells may be an appropriate model for reliable investigations o f the
Legionella/host cell interactions. The inducible dual monocytic and
macrophage-like nature of these cells, which is dependent on cell
differentiation, makes them am endable to studies of L pneumophila
interactions with monocyte-like and macrophage-like cells. In vitro , U-937
cells are monocyte-like; however, they can be differentiated into
macrophage-like cells when stimulated with agents such as phorbol
myristate acetate (PMA), gamma interferon (IFN^y), 1a,-dihydroxyvitamin
D3 (a vitamin D m etabolite), human recombinant interleukin-6 , or retenoic
acid (143, 161). In the undifferentiated state, U-937 cells are non-adherent
and have the ability to divide in culture. However, when differentiated,
these cells possess receptors analogous to macrophages, adhere to
culture vessels, and are incapable of cell replication. In addition, the U-937
cell has been studied extensively in order to determine the role of the
m acrophage in infection and to elucidate features of cell m ediated
immunity (34,61, 142). These cells express both high and tow Ig G binding
receptors as well as the com plem ent receptors type 3 (CR3) and type 4
(CR4) a t levels similar to alveolar macrophages (63,110,159,161).
Furthermore, the U-937 cell is rapidly becoming the cell of choice to study
host-microbe interactions and in investigations to better understand the
effects of modulation of the human immune system. U-937 ceils have also
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been used extensively to study the production and expression o f proteins
by intracellular pathogens such as Salmonella typhi and L pneumophila
when these organisms are wtthin host cells (2,101). This cell is considered a
versatile model in the areas of immunology, pathogenesis and
microbiology (110,115, 138,141).
Attachm ent is the first interaction to occur between a facultative
intracellular bacterial pathogen and its appropriate host cell (11). Many
adherence mechanisms and the structures involved have been
elucidated for a variety of prokaryotes and their eukaryotic host cells (49,
92). Bacterial adherence of an organism to a host cell is believed to be a
tw o stage phenomenon in which an initial weak association occurs,
mediated by forces such as electrostatic, van der Waals and hydrophobic
interactions, and these are followed by a second, much stronger binding
event. Attachm ent of legionellae to human monocytes was initially shown
to be dependent on the deposition of complement on the Legionella
MOMP (12). This organism adheres to and infect cells which are not
professionally phagocytic such as fibroblastic MRC-5 cells, and the
epithelial HEp-2 and Vero cells (134). Since these cells do not possess
com plem ent and Fc receptors normally found on the surface of
mononuclear cells, it is not clear how they become colonized and support
infection of the organism. Furthermore, colonization and intracellular
infection of fresh water am oebae clearly occurs in nature in the absence
of opsonic components (8 ). In addition to the broad range of cells that are
parasitized by L. pneumophila, work by Reynolds and Newbold (145)
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demonstrated that the distal bronchioles and the alveolar spaces of the
human lung typically contain very low levels of complement. Therefore, the
opsonin-independent system of binding may prove an important
mechanism for the initial recognition events of L pneumophila and alveolar
macrophages. Studies to better define these alternative processes are
necessary.
Uptake studies conducted in media containing complement
components showed that Legionella entered host cells by a process
defined as coiling phagocytosis (83). Oldham and Rodgers (134) noted
organism uptake by host cells occurred within banded enclosures. These
were not observed in the present experiments conducted in the absence
of serum. Recently, Horwitz (85) has indicated that when uptake studies are
conducted in the presence of complement, coiling phagocytosis occurs
for many Legionella species; however, it was noted that not all bacteria in
a population are taken up in this fashion. This variation may indicate
organism-based differences or may represent tw o mechanisms of
organism uptake are occurring simultaneously. The present studies
suggest that uptake under opsonin-independent conditions does not
occur via coiling phagocytosis. Other studies addressing Legionella uptake
have described a 24 kD m acrophage infectivity potentiator or MIP protein
as a necessary factor for L. pneumophila uptake by phagocytic cells (31,
51). Yet it is clear that this protein plays no role in the adherence process of
Legionella to macrophages. Isogenic mutants o f L pneumophila devoid of
the MIP protein, binds to host cells, but are not taken-up (29).
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Following uptake of L. pneumophila by monocytes or other cell
types, the organism is contained within tight-fitting phagosomes. The
recruitment of both ribosomes and mitochondria occurs and this
recruitment event appears to be necessary for intracellular replication (87,
134). it is not understood why this organelle recruitment should occur;
however, it may be an important factor for organism survival within host
cells, or may be involved in the supply of nutrients to the organism.
Intracellular survival with subsequent multiplication of Legionella was
apparently dependent on the ability of the organism to uncouple both the
acidification of the phagosomes as well as prevent lysosome fusion with
bacteria-containing phagosomes in the m acrophage (86). Inhibition of
phagosome-lysosome fusion was a crucial factor in the persistence and
subsequent intracellular replication o f legionellae in host cells. The later
stages o f U-937 cell infection occurred from 48-72 h after infection as
docum ented within these cells and demonstrated phagosome distention
with a concom itant increase in the number of bacteria within these
structures. Fulminant cellular infection was followed by bacterial escape
into the cytoplasm of the host cell. Subsequent to this event, release of L.
pneumophila occurred into the extracellular milieu following lysis of the
cells. The factors governing the process of cell escape is not known,
however the L pneum ophila protease, the major secretory protein o f the
organism may be central to bacterial release from the phagosome and
final escape from terminally infected host cells.
This study adds further to the suggestion that opsonin-independent
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processes may be necessary for the initial establishment of m acrophage
infection and that com plem ent m ediated processes could follow as
cellular destruction and local inflammation proceed (91). This idea may be
important as it has been shown that L. pneumophila can bind to a cells in
the absence of serum (75,152). In the absence of specific antibody,
com plem ent did not promote the adherence of L pneumophila to U-937
cells, guinea pig alveolar macrophages or J774 mouse macrophages (91).
The present work taken together with that of Husman and Johnson (91)
indicate that an opsonin-independent attachm ent mechanism may exist
for Legionella and the establishment of infection may be directly related to
this process.
These experiments identified the attachm ent of L pneumophila in an
opsonin-independent fashion and docum ented the morphological events
of intracellular replication following Legionella infection of U-937 cells. In
addition, this study supports the usefulness of U-937 cells as a model for
m acrophage infection in that the intracellular development of Legionella
and the cell-induced changes were similar to those described for guinea
pig alveolar macrophages and human peripheral blood monocytes. The
use of these cells may further assist in clarifying the cellular and molecular
events involved in the development of Legionnaires' disease (75,138,152).
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SECTION III

PARTIAL CHARACTERIZATION OF THE ADHERENCE OF LEGtONEUA
PNEUMOPHILA
TO U-937 AND GUINEA PIG ALVEOLAR MACROPHAGES.

CThe work outlined in this section has been published in the following article:
Gibson, III, F. C., F. G. Rodgers, and A. O. Tzianabos. 1993. Opsoninindependent Adherence of Legionella pneum ophila to MRC-5 and
U937 cells. In Barbaree, Breiman and Dufour: Legionella: Current
Status and Emerging Perspectives. ASM. Washington D.C. pp. 7882.)

3.1 Abstract
Adherence of Legionella pneumophila, strain Nottingham N7, to host
cells occurred in salt solutions devoid of opsonins. Two cell types. U-937
cells and primary explants o f guinea pig alveolar macrophages were used
to study and partially define the opsonin-independent adherence
mechanisms for L. pneumophila. ’ Adhesin' and ’ receptor"
characterization studies were performed by assaying the numbers of
Legionella organisms which had adhered to cells using viable bacterial cell
colony (VBCC) counts and indirect immunofluorescent assays (IFA).
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Receptor saturation studies indicated that a t a multiplicity of infection of
100 2%-8% of the non-opsonized bacterial inoculum was taken-up following

the addition of L. pneumophila to host cells. The single saturation plateau
noted with VBCC counts and IFA suggested a first order kinetic relationship
o f one bacterial ‘ adhesin' per host cell ‘ receptor* for L. pneumophila to
each of the 2 cell types studied. The binding structures were m odified to
determine the broad chemical make-up of the bacterial adhesins and host
cell receptors in com petitive binding assays. In addition, surface
membrane treatments were performed to determine the interruption of
binding due to the enzymatic loss or destruction of particular groups of
molecules; a process of determining the nature of function, through loss of
function. With the exception of the aldehydes, these treatments had no
effect either on the viability of either the microorganism or the host cell.
Adhesin evaluation was m ade using chemical treatments of the bacterial
membrane surfaces and these studies indicated that the adhesin was a
com plex structure consisting o f protein material with lectin-like or
carbohydrate characteristics suggestive of a glycoprotein. However, the
role of lipopolysaccharide could not be excluded. Modification of host cell
membranes indicated that carbohydrate moieties suggestive of glycolipids
on the host cell surface acted as receptors responsible for binding L
pneumophila. However, the nature of these carbohydrate receptors
differed in structure from those saccharides examined in com petitive
binding assays.
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3.2 Introduction

Bacterial recognition of host cells by pathogens is a necessary event
prior to the establishment of infection (11). The concept of bacterial
adherence to substrates is well described and many studies have
demonstrated that bacteria bind efficiently either to particular substrates in
the environment or to cells in host tissues (11.49,74). Work on the
microflora of the mouth established microbial attachm ent-dependent
colonization in humans by microbes and demonstrated the adherence of
microorganisms to both tooth and mucosal surfaces (74). Other studies
suggested that bacterial colonization was frequently dependent on a prior
attachm ent or binding event ( 11). Some microorganisms bind to a variety
of 'in e rt' or non-living substances and some have been shown to bind to
eukaryotic cells while others possess the ability to do both (11,74). To
define the interaction of a bacterium with a host cell, current terminology
identifies the bacterial attachm ent structure as the 'adhesin' and the
structure to which the organism binds as the 're ce p to r' and attachm ent
can occur to epithelial cells, endothelial cells or macrophages. (40,87,92,
134). Fimbriae and the glycocalyx of some bacteria are well-established as
adhesins for several species of bacteria; however, structures such as outer
membrane proteins and lipopolysaccharide are also frequently associated
with adherence (11,49,91,133,187,188).
Attachm ent is a multifactorial event and is dependent on many
factors including availability of appropriate receptors, spatial distribution of
adhesin and receptor moieties, attractive and repulsive forces, physical

factors such as pH and flow rate and the degree of hydrophobicity of the
interacting membranes (11,48) Moreover, the stages of binding usually
involve a sequential two-step process in which a preliminary or weak
binding event is followed by a firm highly specific attachm ent process.
However, the presence or absence of these diverse bacterial structures
are dependent on the phase of growth of the organism and for
pathogens, the stage o f the infectious process. One such process is phase
variation of fimbrial expression.
A rapidly emerging hypothesis is that pathogens may possess several
mechanisms by which they interact with a host cell either a t different
stages of the infectious process or when the participants interact in
differing environments such redundancy has been demonstrated for
Escherichia coli, Salmonella iyphi, Mycobacterium tuberculosis and
Legionella pneumophila (12,60,75, 165). This concept may be an
im portant feature either for determining the conditions necessary for the
establishment of disease or as a microbial strategy for evading the immune
response o f the host (132, 165). Recently, it has been demonstrated that
several pathogens take advantage of a series of immune system-specific
receptors known as integrins and gain entry into various cells through these
relatively conserved group of molecules (4,12,93,162). The integrins most
frequently utilized by microorganisms include the Pi and

integrin subsets,

while the majority of organisms which abuse these receptors are
facultative intracellular pathogens (4,93,162). The Pi integrins are used by
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organisms that possess invasin on their surface, while the 02 group of
receptors including com plem ent receptor type 3 (CR3) are exploited by
organisms that bind directly to these cells either in the presence or in the
absence of com plem ent or immune modulators (4,39, 75,93, 152, 162).
Opsonins, such as complement and antibody, are phagocytosisenhancing molecules and are well-recognized as facilitators for the
destruction of foreign material by phagocytes. Components of the
immune system of the host, specifically antibody and complement, are
deposited on bacteria, thus facilitating the processing mechanism leading
to engulfment by macrophages. In contrast, the mechanisms of direct
recognition of bacteria by macrophages, independent of these
modulators, is poorly understood at best (4, 11, 75,152). In addition, a role
for opsonin-dependent bacterial attachm ent is well-established in the field
of adherence. Direct bacteria-host cell binding in the absence o f these
immune mediators has established that direct attachm ent may be an
im portant mechanism of recognition, especially for some facultative
intracellular pathogens (75,94,152,162). L. pneumophila attachm ent to
host cells, m ediated by complement, has been shown while bacterial
attachm ent between adhesin and host cell receptors may also occur.
Candidate binding structures for L pneumophila include fimbriae, flagella,
outer membrane proteins and lipopolysaccharides (148). The precise
nature of microbial adherence is critical to understanding the mechanisms
by which pathogens establish human disease. Indeed, it is probablr that
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the manner in which bacteria bind to cells directly affects the fate of the
organism in the host cell (178, 182,188).
L. pneumophila is the causal agent o f Legionnaires' disease; a
severe form of lobar pneumonia. This pathogen parasitizes a wide variety
o f mammalian cell types, as well as freshwater protozoa (59,75,87,111,
122,134). In the environment the numbers of legionellae increase when
protozoa are present (59). This amplification prior to colonization o f water
supplies and their aerosolization forms a necessary prelude to the
establishment of human infection. The inhalation of Legionellacontam inated aerosols into the lower respiratory tract (LRT) constitutes the
initial stage of disease and once there, organisms infect alveolar
macrophages (AM 0). Legionella adheres to human derived cells including
monocytes and macrophages in the presence of the serum opsonins
com plem ent or specific antibody (12,89,91). Although the guinea pig has
been adopted as the model of human disease, an acceptable cell model
for the study of legionellosishas not been forthcomming. Guinea pig
alveolar macrophages (GAM), human peripheral monocytes, U-937 cells
and HL-60 cells have been used to investigate bacteria/alveolar
m acrophage interactions; however, none are apparently ideal. U-937 cells
were derived from a human histiocytic lymphoma (170) and these have
been shown to exhibit macrophage-like characteristics such as Fc and
CR3 expression following treatm ent with phorbol myristate acetate (PMA)
(103,16,163,167). Pearlman et al. (138) docum ented uptake and survival
of virulent legionellae within U-937 cells in the presence of serum.
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Previous work centered on the role of com plem ent and specific
antibody-m ediated uptake of this facultative intracellular pathogen (12,89,
91). Legionella attachm ent to peripheral blood monocytes and
macrophages involves the deposition of complement 3b (C3b) on the
bacterial major outer membrane protein (MOMP) of Legionella (12).
Opsonized bacteria are then recognized by host cell complement
receptors. Following opsonin-mediated attachm ent, legionellae are
apparently taken-up by a novel coiling phagocytotic process (83).
It is possible that uptake of L. pneumophila by host cells may not use
an opsonin-dependent mechanism in the initial stage of infection (75, 152).
The rationale for this is based on the observation that respiratory secretions
and the environment of the normal human lung are tow in opsonins (145).
In the light of these observations opsonin-independent adherence
mechanisms for microbial attachm ent were investigated and attempts
were m ade to identify and characterize the adhesins and receptors in the
binding process.

3.3 Materials and Methods
3.3.1 Bacterial Growth and Maintenance
L. pneumophila strain Nottingham N7 was grown and maintained as
previously described (see Section 2.3.1).

3.3.2 Cultivation of U-937 cells
U-937 cells were grown and phorbol ester treated as previously
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described (see Section 2.3.2).

3.3.3 Collection and Cultivation of Guinea pig Alveolar Macrophages
Hartley outbread guinea pigs of 600-650 g (Charles River Labs,
Willmington Mass.) were euthanized with an intraperitoneal injection of
sodium pentobarbitol. The animals were then bled by lacerating the dorsal
aorta prior to the collection of macrophages. Alveolar lavage was
performed with intratracheal injection of 10ml sterile HBSS (pH 7.2) from a
syringe through an 18-gauge needle followed by aspiration of the HBSSm acrophage suspension (Appendix 3). Lavage was repeated 4 times per
guinea pig and this yielded approxim ate 5 x 106 macrophages per animal.
GAM cells were held on ice prior to enumeration. Cells were placed in 50
ml conical centrifuge tubes, centrifuged at 250 x g, counted in an
American O ptical hemocytometer and resuspended in RPMI-1640 medium
containing 10% FBS (Appendix 2) to yield 2.5 x 105 cells/ml. Macrophages
were then distributed to 6 or 24 well cell culture plates and allowed to
adhere for 2h in a humid environment at 37°C in 5% CO 2 prior to use.

3.3.4 Treatments
All treatm ent were prepared fresh in HBSS, adjusted to pH 7.2 and
filter sterilized through a 0.22 urn pore-size filter prior to use.
Concentrations, treatm ent times and the rationale for cell-surface
modifying agents as well as monosaccharides are shown in Tables 3.1,3.2
and 3.3.
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3.3.5 Infection Assay
Monolayers o f U-937 cells or guinea pig alveolar macrophages in
each 6 or 24 well plates were washed 4 times with HBSS to remove serum
opsonins from the culture media and fresh HBSS without serum was added.
The cells were then inoculated with L pneumopNIa N7 a t a MOI of 100. For
com petitive binding studies sugars were added to cells in each well 10 min
prior to the addition o f organisms. Surface modification of either the
prokaryotic or eukaryotic cells was done prior to adding organisms to host
cells. Following each treatm ent regime, legionellae were allowed to
adhere for 1 h. Monolayers were then washed 3 times with HBSS to remove
non-adherent bacteria. Adherence was assayed by VBCC counts and IFA
and the data was com pared with untreated controls.

3.3.6 Detection: Viable Bacterial Cell Colony Counts
Inoculated monolayers in 24-well culture plates were lysed a t room
temperature by adding to each 1ml sterile distilled water for 30 min
followed by vigorous aspiration with a sterile pasteur pipette. The resultant
lysates were serially 10-fold diluted in 1% peptone and 25 *il of each dilution
was plated in duplicate on BCYE-a agar. Colonies were counted a t 72 h
and the number of bacteria in each origional sample was evaluated.

3.3.7 Detection: Immunofluorescent Assay
Prior to adding U-937 or GAM cells to 6 -well cell culture plates, 22
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Competitive binding Treatments

Table 3.1: Competitive Binding Experiments*
AGENT*

CONCENTRATION
lOOmM
lOOmM
lOOmM
lOOmM
lOOmM
lOOmM
lOOmM

N-acetyl-D-glucosamine (NAc Glu)
N-acetylgalactosamine (NAc Gal)
N-acetylneuraminic acid (NAc Neu)
a-D(-) fucose
B-D(+)-glucose
D(+>mannose
D(+)-galactose

FUNCTION

Competitive
binding

•Each of the select treatments were added to host cells 10 min prior to
infection.
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Eukaryotic Cell Treatments

Table 3.2: Eukaryotic Treatments

AGENT

CONCENTRATION
Activity (units/mD

TREATMENT
TIME (min)

FUNCTION

Enzymes
Chymotrypsin
Lipase
Neuraminidase
Pepsin
Protease
Trypsin

0.005
50.0

30
30
30
30
30
30

Glutaraldehyde
Formaldehyde
Nonidet P40

0 .1%
1.0%

10
10

0.005%

60

Sodium
m etaperiodate

5mM

10

Oxidation of
carbohydrates

3ng/ml

10

Inhibition of micro
tubule formation

100ng/m l

60

Binds to mannose

100ng/m l

60

Binds to N-acetylglucosamine

0.1
100.0
1.0
100.0

Degrades
sensitive receptor
on host cells

Agent

Cytochalasin B

Immobilization of
protein moieties
Oxidation of lipids

Lectins
Concanavalin A
(Con A)
Wheat Germ
Agglutinin
(WGA)
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Prokaryotic Cell Treatments

Table 3.3: Bacterial Treatments

AGENT

CONCENTRATION
ACTIVITY (units/mD

TREATMENT TIME
(min)

FUNCTION

Enzymes
B-galactosidase
Chymotrypsin
Lipase
Neuraminidase
Protease
Trypsin

5
250

60
60
60
60
60
60

Degradation of
protein/sugar
containing
moieties on the
surface o f L
pneumophila

0 . 1%

10

Immobilization
moieties

lOmM

60

Oxidation of
carbohydrate
moieties

100

250
100
20

Fixative
Glutaraldehyde
o f protein
Oxidizing Agent
Sodium
m etaperiodate
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mm 2 sterile glass coverslips were added and the cells were allowed to
adhere to the coverslips. After com petitive binding and prokaryotic or
eukaryotic cell surface treatments had been performed, monolayers were
inoculated with L. pneumophila as described in the infection assay (3.3.4).
After 1 h incubation, host cells were washed 3 times to remove
unbound bacteria after which cultures were fixed with 10% formalin in PBS
(pH 7.2) for 1 h a t 25°C. After three further washings with PBS, monolayers
were treated with rabbit polyclonal L pneumophila strain N7 antiserum for
1 h a t 37°C. Unbound globulin was removed by washing 3 times with PBS
and goat anti-rabbit FITC conjugated antibody (Boehringer Mannheim,
Indianapolis, IN) was added for 1 h. After multiple washings with PBS to
remove unbound globulin, cells were counter-stained with 0 .01% propidium
iodide in PBS for 30 min and were further washed three times with PBS. Cells
on coverslips were air-dried and mounted in glycerol containing 1% 1Adiazobicycto (2.2.2) octane (DABCO) (Sigma) as a anti-quenching agent.

3.3.8 Detection: Criteria for Assessing Data
VBCC counts were an average of 10 trials, each performed in
duplicate and the number of bacteria bound either to control host cells or
to cells following the various treatm ent regines were calculated as colony
forming units (cfu). Adherence was expressed as a percentage of control
cells. VBCC count data were statistically analized by determining standard
error using Statview software package (Abacus Concepts) on a Macintosh
Cetris 610 microcomputer. IFA results were the average of 3 trials
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enumerating adherent bacteria on the first 200 cells observed per trial.
Data were calculated as the number of bacteria bound to each host cell
and expressed as a percentage of control cells. A 50% change in
adherence data was the criterion used to assess significance o f a
particular treatm ent for both VBCC counts and IFA studies.

3.3.9 Binding Kinetics
Wells containing U-937 cells (5 x 105 cells/ml) or GAM cells (2.5 x 105
cells/ml) in either 6 or 24 well cell culture plates were washed 5 times with
HBSS to remove serum contained opsonins. Fresh HBSS was added to each
well containing cell monolayers and these monolayers were infected with
increasing 10-fold multiplicities o f infection (MOI) of L pneumophila
organisms. Following a 1 h incubation period a t 37°C, unbound bacteria
were removed by multiple HBSS washings. Infected cell monolayers were
then processed for VBCC counts or IFA detection respectively.

3.4 Results
Saturation kinetics for U-937 and GAM cells indicated that host cell
receptor saturation was effected a t the equivalent o f 1000 bacteria per
host cell or 2-5 x 108 bacteria added to 2-5 x 105 host cells. These findings
were similar for each cell type and assay method (Fig. 3.2.3.3.3.4,3.5).
Due to unacceptible levels of non-specific binding to the plastic culture
plates a t receptor saturation a MOI of 100 was selected for all subsequent
studies. This gave an inoculum size close to receptor saturation levels and
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minimized non-specificity while retaining the effectivness o f 50% or greater
changes in binding data.
Following, a 1 h incubation with a 100 MOI of virulent L. pneumophila,
host cells bound approximately 2% to 8% of the bacterial inoculum as
indicated both by VBCC counts and IFA (see Fig. 3.2,3.3,3.4,3.5).

3.4.1 Competitive Binding Treatments
Co-incubation of L pneumophila with host cells in the presence of
monosaccharides in a com petitive fashion indicated that none of the
tested simple sugars outlined in Table 3.1 inhibited opsonin-independent
attachm ent. Similar data was generated by VBCC and IFA counts (Fig. 3.6,
3.7,3.8,3.9). However, carbohydrate oxidation by sodium m etaperiodate
treatm ent of either the organism or host cells indicated the im portance for
carbohydrates, other than those tested, in the attachm ent of Legionella to
GAM cells.

3.4.2 Host Cell Surface Modification
In an effort to determine the general chemical moiety of the host
cell receptor used by L. pneumophila to attach to host cells, cell surface
membranes were chemically treated to digest or remove potential
receptors. These studies indicated that U-937 and GAM cells possessed
somewhat similar profiles for their adherence to receptors (Fig. 3.10, 3.11,
3.12.3.13) treatments outlined in Table 3.2. The receptor structure was
apparently carbohydrate in nature with likely lipid components (Fig 3.18).
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M etaperiodate oxidation of saccharides on the surfaces of host cells
strongly inhibited bacterial attachm ent and was suggestive of
carbohydrates in the receptor complex. Likewise, lipids may be involved
with adhesin recognition as Nonidet P40 solubilization of lipids slightly
interfered with the binding of legionellae to U-937 and GAM cells while lipid
cleavage by lipase treatm ent gave variable results. Host cell surface
proteins modified by trypsin, chymotrypsin protease or pepsin did not
significantly influence the adherence of the organism to these cells. In
addition, neuraminidase did not abolish adherence suggesting no role for
neuraminic acid residues in binding. The addition of the lectins wheat germ
agglutinin (WGA) or concanavalin A (Con A) strongly interupted
attachm ent, supporting a role for lectins or lectin-like molecules on the
bacterial surface as required for the attachm ent event. WGA has binding
specificity for N-acetyl-glucosamine and neuraminic acid while Con A
attaches to mannose residues. These data suggested an inhibitory effect
would be expexted for these saccharides tested in com petitive binding
experiments; however, this was not the case.
Inhibition of microtubule formation by pretreating host cells with
cytochalasin B, thus uncoupling the processes of organism attachm ent
from organism uptake, showed no effect on bacterial binding. Treatments
of host cell surfaces indicated essentially similar receptor profiles; however,
some differences were noted between these cell types. With the
exception of the aldehyde fixatives, the host cell treatments did not
significantly affect host cell viability.
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3.4.3 Bacterial Surface Treatment
Adhesin modification studies performed using the treatments
outlined in Table 3.3 indicated that a complex bacterial structure was
involved in this opsonin-independent attachm ent process. All treatments
with the exception of neuraminidase produced significant decreases in L
pneumophila attachm ent to the host cells. From these data, the adhesin of
L. pneumophila would seem most likely to be a protein containing
carbohydrate and possibly lipid components (Fig. 3.14,3.15,3.16,3.17). The
most likely structure is a glycoprotein located on the bacterial surface
which interacts and binds to a glycolipid on the host cell membrane (Fig.
3.18) All of the protein modifying agents tested, trypsin, protease and
chymotrypsin significantly reduced bacterial attachment. In addition, the
data from the m etaperiodate oxidation of organism surface indicated that
carbohydrates were necessary for binding of Legionella to both U-937 and
GAM cells while lipase treatm ent moderately affected attachm ent. Noted
that none of these adhesin modifying agents affected bacterial viability as
determined by VBCC counts.
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Figure 3.2: Binding of L pneumophila to U-937 cells as measured by VBCC
counts. U-937 cells were seeded at 5 x 105 cells/well and increasing 10-fold
multiplicities of infection o f bacteria were added to the cells. Ratios of cfu
per U-937 cell were determined by dividing the resultant lysate value by the
number of host cells per well. Host cells approached saturation with L
pneumophila with an inoculum of 5x 107 cfu/m l and this approximated 1.7
bacteria per U-937 cell. Each point is the average of 3 trials.
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Figure 3.3: Binding of L pneumophila to U-937 cells as measured by IFA. U937 cells were seeded at 1 x 10* cells/well and increasing 10-fold
multiplicities of infection of bacteria were added to the cells. Each point is
the average of 3 trials enumerating the total number of fluorescent
bacteria bound to 200 host cells. Host cells approached saturation with L
pneumophila with an inoculum of 1.5 x 108 cfu/m l and this approximated 3
bacteria per U-937 cell.
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Figure 3.4: Binding of L. pneumophila to guinea pig alveolar macrophages
cells as measured by VBCC counts. Guinea pig alveolar macrophages
were seeded a t 2.5 x 105 cells/well and increasing 10-fold multiplicities of
infection of bacteria were added to the cells. Ratios of cfu per guinea pig
alveolar m acrophage were determined by dividing the resultant lysate
value by the number of host cells per well. Host cells approached
saturation with L. pneumophila with an inoculum of 2.5 x 107 cfu/ml and this
approximated bacteria per guinea pig alveolar macrophage. Each point
is the average of 3 trials.
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Figure 3.5: Binding of L pneumophila to guinea pig alveolar macrophages
as measured by IFA. Guinea pig alveolar macrophages were seeded at
7.5 x 105 cells/well and increasing 10-fold multiplicities o f infection of
bacteria were added to the cells. Each point is the average of 3 trials
enumerating the total number of fluorescent bacteria bound to 200 host
cells per trial. Host cells approached saturation with L pneumophila with an
inoculum o f 7.5 x 107 cfu/m l and this approximated bacteria per U-937 cell.
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Competitive inhibition U-937 VBCC counts
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Figure 3.6: Competitive inhibition of L pneumophila binding to U-937 cells
as measured by VBCC counts. Each value represents the average of 10
trials enumerating percent bacterial adherence of controls with co 
incubation of legionellae with the saccharides listed in Table 3.1.
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Competitive Inhibition U-937 IFA
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Figure 3.7: Competitive inhibition of L. pneumophila binding to U-937 cells
as measured by IFA. Each value represents the average of 3 trials
enumerating the to ta l number of fluorescent bacteria bound to 200 host
cells per trial as percent adherence of controls with co-incubation of
legionellae with the saccharides listed in Table 3.1.
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Competitive inhibition GAM VBCC counts
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Figure 3.8: Competitive inhibition of L pneumopNIa binding to guinea pig
alveolar macrophages as measured by VBCC counts. Each value
represents the average of 10 trials enumerating percent bacterial
adherence o f controls with co-incubation of legionellae with the
saccharides listed in Table 3.1.
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Figure 3.9: Competitive inhibition of L pneumopNIa binding to guinea pig
alveolar macrophages as measured by IFA. Each value represents the
average of 3 trials enumerating the total number of fluorescent bacteria
bound to 200 host cells per trial as percent adherence of controls with co
incubation of legionellae with the saccharides listed in Table 3.1.
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Surface Membrane Treatment U-937 cell: VBCC counts
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Figure 3.10: Surface membrane treatm ent of U-937 cells with agents in
Table 3.2. Percent adherence of legionellae to U-937 cells as measured by
VBCC counts. Each value represents the average of 10 trials.
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Surface Membrane Treatment U-937 cell: IFA
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Figure 3.11: Surface membrane treatm ent of U-937 cells with agents in
Table 3.2. Percent adherence of legionellae to U-937 cells as measured by
IFA. Each value represents the average of 3 trials enumerating the total
number of fluorescent bacteria bound to 200 cells per trial.
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Figure 3.12: Surface membrane treatm ent of guinea pig alveolar
macrophages with agents in Table 3.2. Percent adherence o f legbnellae
to guinea pig alveolar macrophages as measured by VBCC counts. Each
value represents the average of 10 trials.
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Figure 3.13: Surface membrane treatm ent of guinea pig alveolar
macrophages with agents in Table 3.2. Percent adherence of legionellae
to guinea pig alveolar macrophages as measured by IFA. Each value
represents the average o f 3 trials enumerating the total number of
fluorescent bacteria bound to 200 cells per trial.
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Surface Treatment L pneumophila VBCC counts: U-937
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Figure 3.14: Surface membrane treatm ent of L pneumophila with agents in
Table 3.3. Percent adherence o f legionellae to U-937 cells as measured by
VBCC counts. Each value represents the average of 10 trials.
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Figure 3.15: Surface membrane treatm ent of L. pneumophila with agents in
Table 3.3. Percent adherence of legionella to U-937 cells as measured by
IFA. Each value represents the average of 3 trials enumerating the total
number of fluorescent bacteria bound to 200 host cells per trial.
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Figure 3.16: Surface membrane treatm ent of L pneumophila with agents in
Table 3.3. Percent adherence of legionellae to guinea pig alveolar
macrophages as measured by VBCC counts. Each value represents the
average of 10 trials.
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Surface Treatment L pneumophila IFA: GAM
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Figure 3.17: Surface membrane treatm ent of L pneumophila with agents in
Table 3.3. Percent adherence o f legionella to guinea pig alveolar
m acrophages as measured by IFA. Each value represents the average of
3 trials enumerating the total number of fluorescent bacteria bound to 200
host cells per trial.
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3.5 Discussion and Conclusions

Legionellae are facultative intracellular pathogens. They have an
intimate relationship with the cell-mediated immune (CMI) system of the
host in that they primarily infect alveolar macrophages and mediating CMI
is critical to recovery. Legionella organisms can be controlled with
antimicrobial therapy using antibiotics such as erythromycin, tetracycline,
ciprofloxacin or rifampin, normally used in com bination therapy (151,177).
However, people often succumb to Legionnaires' disease despite the
implementation of appropriate and aggressive therapy soon after
pneumonia is diagnosed (68). A fuller understanding of the interactions
between this organism and the cells it infects is necessary for the
developm ent of alternative treatm ent regimes. In the absence of a toxic
etiology for disease, binding is frequently the first event in bacterial infection
which eventually leads to cell death or tissue invasion. This recognition
process is especially necessary for diseases associated with facultative
intracellular pathogens such as L. pneumophila (75,87,92,162). The binding
process is complex and propably multi-factorial in form and organisms may
possess several sets of adhesins which are used under different
circumstances for binding to alternative cell receptors (11). Moreover, to
add to the already existing complexity o f measuring adherence, the
methods used to assess attachm ent inevidably produce contradictory
results making interpretation all the more difficult. In this study, the criterion
used to deem a treatm ent significant for modification o f L pneumophila
adherence was a 50% reduction of the experimental or treatm ent data
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compared with untreated controls.
Lectins are well known attachm ent factors for bacteria (133). For
Legionnaires' disease to develop, the organism and cells of the undergo a
recognition event which is followed by wash-resistant attachm ent (50,152).
Several bacterial structures have been suggested as adhesins such as
mucopolysaccharide capsules, lipoteichoic acid, various lectins, fimbriae,
flagella, lipopolysaccharide and outer membrane proteins (11,40,49,84,
132,133,188). Although the adhesins for many bacteria and their
counterpart host cell receptors have been identified, few binding
mechanisms have been described in detail (92,93,132). For L.
pneumophila flagella, fimbriae, lipopolysaccharide and outer membrane
proteins have been proposed as potential adhesins (149), but none has
been directly im plicated. However, it is clear that the characterization of
the binding phenomenon of L pneumophila to host cells is central to
elucidating the pathogenesis of this disease. Work by Gibson and Rodgers
(75) demonstrated that L. pneumophila binds to various host cells in the
absence of opsonins in a wash resistant manner (see Section 2 and this
report). These studies demonstrated that the Legionnaires' disease
bacterium bound to U-937 cells in the absence of either com plem ent or
specific antibody. In this study it was demonstrated that a MOI of 100 was
appropriate for studies involving adherence of Legionella to
macrophages. In addition, the preliminary characterization of the bacterial
and host cell molecules involved in binding are described. This mechanism
of bacterial attachm ent to host cells would appear to be a relatively
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L. pneumophila Adhesin
Glycoprotein

L. pneumophila

Host cell Surface

U-937 or GAM cell Receptor
Glycolipid

Figure 3.18: Schematic Representation of L pneumophila adhesin and host
cell receptor for opsonin-independent attachm ent of this organism to U937 or guinea pig alveolar macrophages.
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conserved process as many similarities exist between adhesin and
receptor profiles for U-937, GAM and MRC-5 cells (75, unpublished
observations).
To identify the process by which Legionella were taken-up, cells were
pretreated with cytochalasin B, a potent inhibitor of microtubule formation
(50). This was used to separate active invasion or phagocytic uptake from
adherence. The cytochalasin treatm ent had no effect on attachm ent of L
pneumophila to U-937 or GAM cells. Complement-dependent uptake of L.
pneumophila by phagocytes requires the preliminary deposition of the
com plem ent components C3b or C3bi on the surface o f the MOMP of the
organism. Following this coating process, opsonized organisms were takenup via the complement receptors (CR) type 1 or CR type 3 on human
monocytes (12). Preliminary data on the identification of the adhesin(s) and
receptor(s) necessary for binding L pneumophila to host cells in the
absence of com plem ent or serum suggested that this process occurred in
a different manner. The use o f U-937 and GAM cells for these experiments
was justified by the observation that this pathogen infects the resident
macrophages of the lung. The monosaccharides selected for com petitive
inhibition studies did not interfere with binding. Clearly, mono-, di, or
oligosaccharides other than those examined may have blocked binding;
however, the requirement to screen many thousands o f compounds
rendered this unfeasable. Subsequent studies examined the role o f
carbohydrates in attachm ent by oxidizing these compounds on bacterial
or host cell surfaces. Indeed, treatm ent of L. pneumophila with surface
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modifying agents indicated that the adhesin was a complex structure
containg protein, carbohydrate and possibly lipid. It is possible that the
adhesin in question was the MOMP of Legionella; as is the case for opsonindependent binding. The lipopolysaccharide of L pneumophila is very
closely associated with MOMP to the point where purified LPS is inevidably
contam inated with MOMP and vice versa. LPS is an im portant structure for
both the establishment of disease and as an activator of the immune
system (119). Isolated LPS from various organisms has been shown to bind
to human monocytes via several key structures including the CD 11/CD18
Leu-CAM com ple (a 80-kDa protein), the glycolipid CD 14 (a lectin-like
molecule), as well as LPS binding proteins found in human serum (72,104,
188, 189). LPS requires further examination in binding studies.
Receptor m odification studies suggested that the proposed host cell
receptor responsible for binding L. pneumophila was comprised of
carbohydrate and lipid material but lacked protein and was possibly a
glycolipid moiety. Wether this is identical to the previously described
glycolipid CD 14 is not clear. However, it does seem clear that in the
absence of com plem ent the glycoprotein receptors CR1 and CR3 were
not involved in binding L. pneumophila. The non-opsonin adhesin/receptor
process outlined in Figure 3.17 may be an alternate even critical
mechanism for Legionella-host cell attachm ent especially early in disease
when inflamation and hence increased opsonin levels have not occurred
(75, 152). This becomes o f greater significance given the observations of
Reynolds and Newbold (145) that the lung and secretions are almost
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devoid of the opsonins complement and IgM. Following Legionellainduced tissue destruction, the increase in opsonin concentration may well
augm ent opsonin-mediated uptake and thus facilitate disease.
It was clear that m etaperiodate oxidation and treatm ent with
various lectins strongly inhibited L pneumopNIa attachm ent. Lectins are
proteinaceous structures which possess the ability to recognize specified
carbohydrate moieties. The type 1. Pap and S fimbriae often found in
members of the Enterobacteriaceae frequently show lectin activity.
Indeed, for these organisms fimbriae are believed to be central to
attaching bacteria to sufaces (90,118,123,132). Type 1 fimbriae bind to omannose residues (1,133). Although, the major subunits vary widely from
species to species the tip is a conserved structure across most type 1
fim briae of the Enterobacteriaceae (49). This structural organization is
com mon among other fimbriae such as the Pap pili and S fimbriae that
recognize a-Gal (l->4) (J-Gal and sialic acid containing glycoconjugates
(90,121). In these studies, D-mannose did not com pete with L
pneum ophila for binding sites for U-937 or GAM cells. Although L
pneumophila possess fimbriae, it seems that Type 1 fimbriae are not
involved in opsonin-independent adherence described. In addition to
these findings the use of galactose, N-acetyl neuraminic acid and
neuraminidase failed to inhibit L pneumophila adhesion to these cells. The
contradictory data from the com petitive assays with mannose and Nacetyl-galactosamine, and the lectins Con A and WGA (these binding
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ligands for mannose and N-acetyl galactoseamine respectivly) may reflect
steric phenomena involving lectin recognition of the appropriate
saccharides in the proximity of the host cell receptor. Data from the
m etaperiodate oxidation of carbohydrates supported these suggestions.
It Is also possible that Legionella possess a myriad of attachm ent
molecules and that the organism can m odulate their expression as
required. A comprehensive characterization of both adhesin and
receptor will require their isolation and purification; however, these
procedures are complex (11,60,74,165). M ucopolysaccharide capsules
are important for the adherence of bacteria to oral tissue cavity (74), while
Bacteroides fragilis possess polysaccharides which are potent mediators of
abscess form ation (175). Capsules have also been shown to decrease
both antigenicity and decrease the phagocytotic expression of
macrophages for encapsulated bacteria (125). Although data is
conflicting, it would appear that Legionella do not produce a capsule
(150). Studies are further com plicated in that traditional laboratory batch
growth procedures tend to select for organism populations not expressing
adhesins. This is brought about because nutrients are present to excess
and so there is no advantage for their expression. Variations in culture
conditions for bacterial populations used in adherence study may produce
widely divergent results.
Facultative intracellular bacterial pathogens such as L pneumophila,
L. monocytogenies. M. tuberculosis, S. typhi and Y.pestis belong to this
group of facultative intracellular pathogens and all have demonstrated
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fascinating strategies for infecting and surviving within host cells (60,83,75,
125,166). Legionellosis has serious implications for the health of the nation
especially given the spectacular outbreaks that occur from tim e to time.
Antimicrobial intervention which is not preventitive, may not successfully
eradicate the pathogen. In addition, resistant strains have been reported
and organisms cannot be removed from the environment entierty. As a
consequence alternatives to conventional therapeutic regimes are
required for to prevent severe cases of legionellosis am ong susceptible
individuals. A vaccine to augment antibiotic therapy is required.
Attachm ent to the alveolar m acrophage is the first stage of Legionelloinduced disease; therefore, it may serve as a potential attack site for
vaccine research. A vaccine that is capable of interrupting or preventing
this binding event may prove an efficacious addition to the clinical
armarmentarium for the prevention of Legionnaires' disease.
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SECTION IV

ASSESSING THE ROLE OF COMPLEMENT RECEPTORS FOR ATTACHMENT OF
LEGIONELLA PNEUMOPHILA TO U-937 CELLS.

(The work outlined in this Section has been published in abstract form:
Gibson, III, F. C., and F. G. Rodgers. 1994. Role of com plem ent receptors in
non-opsonin m ediated adherence of Legionella pneumophila to LI937 cells. Abst. Gen. Meeting ASM. D-49: p 104.)

4.1 Abstract
In order to define the role of CR1, CR3 and CR4 in the opsoninindependent adherence process of legionellae to macrophages, a series
of monoclonal antibodies to CR1 (CD 35), CR3 (CD 1lb + CD 18) and CR4
(CD 1lc + CD 18) were used both individually and in combination to block
these potential binding sites. These monoclonal antibodies either individually
or in combination failed to inhibit the binding of L pneumophila to U-937
cells as com pared with untreated control cultures. It would seem that
opsonin-independent attachm ent of L pneumophila to U-937 cells is
m ediated by host cell binding ligands other than CR components.
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4.2 Introduction

The nature of Legionella pneumophila attachm ent to host cells is
poorly understood. Moreover, the mechanism by which intracellular
pathogens infect host cells has been shown to be critical for the
establishment of infection. Initial investigations by Horwitz e t al. (87)
demonstrated that uptake of L pneumophila by human monocytes was
m ediated by the deposition of complement onto the MOMP of Legionella
organisms. This complex is then bound to the com plem ent receptors CR1
and CR3 (12). In addition, the LPS of L. pneumophila has been shown to
activate the classical complement cascade (119) and this observation
supports the opsonin-dependent process of host cell infection. Work from
our laboratory (76, and this reprot Section II) demonstrated that direct
attachm ent of L. pneumophila to U-937 cells occurs independent of
opsonins and that this process may be central to the initiation of disease
(75,76,91).
Cell m ediated immunity (CMI) in conjunction with humoral support is
critical to the recovery from disease. Macrophages and
polymorphonuclear leukocytes (PMNL) are the primary phagocytes
involved in the eradication of these bacterial pathogens. The process by
which these cells engulf and destroy bacteria is well documented;
however, they fail to function adequately when the host is challenged by
the facultative intracellular pathogen, L. pneumophila. Normally,
macrophages first engulf, internalize and process invading microorganisms
before destroying them. In functional terms, the phagocytic cell appears
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to be an unattractive host for Legionella; despite this, Legionella have the
ability to parasitize these cells. The processes by which these bacteria gain
access to host phagocytes and then evade their m icrobicidal activities are
diverse. The successful activation of such processes directly a ffe ct the
survival o f either the organisms or of the host cells in the ensuing struggle for
supremacy. Two groups of bacterial attachm ent mechanisms to
phagocytes have been identified and these include opsonin-dependent
and opsonin-independent processes. Opsonin-dependent mechanisms of
microorganism uptake have been elaborated in greater detail then those
binding systems which occur via opsonin-independent processes.
Opsoninization involves two processes in which organisms pre-coated with
specific antibody bind to phagocytic cells usually through Fc receptors.
This binding induces cellular production of reactive oxygen metabolites
(187) which are critical to the breakdown of foreign material. In contrast,
those pathogens that bind to com plem ent receptors (CR1 or CR3) via
com plem ent do not elicit an oxidative burst (182,187). Organisms which
use CR1 and CR3 for entry into the intracellular matrix of the host cell are
afforded a potentially safer route for intracellular infection than those
entering via Fc receptors.
Recently, the heterodimeric fc integrin family of leukocyte cell
surface adhesion molecules have been shown to be important for binding
prokaryotic and eukaryotic pathogens, as well as bacterial surfaceexpressed components to host cells (4,12,162). This family of leukocyte
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receptors includes LFA-1, CR3, and CR4 (p i 50,95), of which CR3 and CR4
are important mediators for binding the third com ponent of com plem ent
(C3) as well as for mounting a functional immune response (157,158,159).
As a group, these molecules comprise an a (CD1 la , b, c) and p (CD 18)
subunit with the p subunit conserved by all members o f the integrin group
(167). The human histiocytic lymphoma, U-937 cell line, has a receptor
profile similar to that of both monocytes (pre-phorbol ester activation) and
macrophages (post activation) (161). Known opsonin receptors on the
surface of activated U-937 cells include, fibronectin-binding protein, CR1,
CR3, CR4 and Fc receptor for IgG (158,161, 162,167). The profile and
distributions of these receptors is similar to that for human alveolar
macrophages and make this cell an attractive model for the study of
direct attachm ent of L pneumophila via complement receptors (12).

4.3 Materials and Methods
4.3.1 Bacterial Growth and Maintenance
L pneumophila strain Nottingham N7 was grown and maintained as
previously described (Section 2.3.1).

4.3.2 U-937 Cell Cultivation
U-937 cells were grown and phorbol ester treated as previously
described (Section 2.3.2).
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Tabt* 4.1: Monoclonal Antibodies used for Complement Receptor
Inactivation
Type

Raised
Against

Concentration
Used

Blocking Function

General:
G oat anti-Rabbit

100 ng/ml

Fc Receptor

Clone Products.b
Ml/70.15.11.5
CD lib
M 18/2a.l2.7
CD 18

50 ng/ml
50 ng/ml

CR3 (a subunit)
CR3 and CR4 (p subunit)

YFC 118.3

CD 18

50 ng/ml

CR3 and CR4 (p subunit)

E ll
Sp2/0-Agl4

CD 35
CD 11c

50 ng/ml
50 ng/ml

CR1
CR4 (a subunit)

a incubation conditions were 60 min at 37°C for all treatments

Clones YFC 118.3, El 1, and Sp2/0-Agl4 are o f mouse origin and were
obtained from Serotec International, Indianapolis, IN. Monoclonal
antibodies from clones M l/7 0 .15.11.5 and M18/2a. 12.7 were rat anti
mouse and possessed cross-reactivity with human epitopes. These were
kindly donated by Dr. A. Sloan.
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Complement Receptors CR1, CR3 and CR4

C3bi
CD lib

CRT

CR3*

CR4
(pi 50.95)

Figure 4.1: Complement receptors responsible for binding C3b
and C3bi. * Denotes those receptors responsible for opsonindependent attachment of L. pneumophila to host cells. Adapted
from Springer 1984.
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4.3.3 Receptor Inhibition Studies Using Specific Monoclonal Antibodies

U-937 cells grown on coverslips in 6-well cell culture plates previously
treated with PMA were washed 5 times with HBSS to remove RPMI-1640
and serum components (Appendix 1). The cells were resuspended in fresh
HBSS and host cell Fc receptors were blocked by incubation at 37°C for 1 h
with a non-specific rabbit antisera (generated in goat) used at a
concentration of 100 ng/m l (Table 4.1). Following three washes to remove
unbound globulin, monoclonal antibodies specific for CR1, the a and p
components o f CR3 and the a and p subunits of CR4 were added
individually as well as in com bination to blockreceptor activity on U-937
cells. The monoclonal antibodies used to block CR1 were o f mouse origin
and were directed against human epitopes. The CD 1lb , CD 1lc and CD
18 monomers of CR3 and CR4 on U-937 cells were either rat anti-mouse,
mouse anti-human or rat anti-human in origin Gable 4.1). The rat anti-mouse
sera were specific for human CD 1lb and CD 18 glycoproteins and it is
known that these monoclonal antibodies recognize identical moieties
conserved between human and murine systems. Treated cell cultures
were incubated for lh a t 37°C, after which unbound antiserum was
removed by washing three times with HBSS. L. pneumophila were added to
these monoclonal antibody treated U-937 cells at a MOI of 100 in HBSS.
Cultures were then incubated for lh at 37°C, washed three times with HBSS
and assayed by VBCC counts.
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AA Results
The treatm ent of U-937 cells with goat anti-rabbit IgG facilitated
recognition o f the monoclonal antibodies each to the appropriate ligand
and prevent loss of monoclonal activity to Fc receptors. This pretreatment
was not inhibitory to the binding of L pneumopNIa (Fig. 4.2).
Phorbol ester treated U-937 cells express CR1. CR3 and CR4 (161).
When added to U-937 cell cultures monoclonal antibody to the human CR1
(CD 35) did not inhibit the binding of the organism to U-937 cells (Fig. 4.2).
Two separate sets of monoclonal antibodies were used to block CR3
(Table 4.2) the major structure responsible for uptake of the Legionnaires'
disease bacterium in the presence of complement. Data generated from
these antibody blocking studies indicated that CR3 was not involved in
organism binding. No inhibition of bacterial binding was recorded using
these levels of monoclonal antibodies (Fig. 4.2).
Although, CR4 is weakly expressed on alveolar macrophages and U937 cells it is structurally analogous to CR3 and is a potent receptor for C3bi
(162). To neutralize the CR4 receptor monoclonal antibodies directed to
human CD 1lc and CD 18 (Table 4.1) were used separately or in
com bination to block either the individual subunits or the receptor
complex. These antibodies failed to neutralize the binding of L
pneumophila to U-937 cells. It was clear that CR1, CR3 and CR4 and their
substituant sub-units did not function as receptors for L. pneumophila in
opsonin-independent adherence (Fig. 4.2).
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CR1, CR3 end CR4 VBCCC

Figure 4.2: Monoclonal antibody blocking of CR1 (CD 35), CR3 (CD 18
and/or CD 1lb ) and CR4 (CD 18 and/or CD 1lc ) on the surface of U-937
cells for inhibition of L. pneumophila-U-937 cell binding as measured by
VBCC counts. Fc receptors were inactivated using a goat anti-rabbit
antiserum prior to monoclonal antibody incubations. Each plotted data set
is a mean o f three trials.
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4.5 Discussion and Conclusions

Bacterial attachm ent to host cells is the first interaction of a
pathogen with the host. This adherence phenomenon is an essential step in
intracellular infection, whether for phagocytic or other cells (11,165). it
would appear that the mechanisms used by phagocytes to take-up
intracellular pathogens profoundly influences the development of cellular
infection (11, 178,182,188).
L pneumophila has been shown to infect an extensive array of cells
including am oebae, epithelial cells, fibroblasts, macrophages and
monocytes (59, 75,87,94, 111,122, 134, 152). In opsonin-mediated
adherence, the fragments C3b and C3bi of the com plem ent system coat
the organism prior to binding of legionellae to the surfaces of monocytes
via CR3 and to a lesser extent CR1.
Recently, opsonin-independent binding of this organism to U-937 cells
has been reported (75,76,91,152, and Sections 2 and 3 of this report).
Preliminary investigations to characterize receptor structures have proved
inconclusive but suggest a glycolipid moiety as the adherence receptor for
MRC-5, U-937 and GAM cells. The monoclonal antiboby blocking studies
offer some conferm ation of these findings in that the glycoprotein
receptors CR1, CR3 and CR4 were not involved in the direct binding of L.
pneumophila to host cells.
Two o f the three com plem ent receptors CR3 and CR4 (p i 50.95)
responsible for binding various C3 components on the surface of
phagocytes are integrins while CR1 is not. These heterodimeric integrins
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which bind C3bi consist of a unique a subunit and a common p subunit. The
CR3 receptor is responsible for binding and uptake of com plem ent coated
legionellae (12,162).
Infection of U-937 cells in the absence of com plem ent was
achieved by infecting these cells with legionellae in HBSS. The role o f CR
molecules during com plem ent-independent adherence of L pneumopNIa
was assessed using a series of m onoclonal antibodies. The CR1 receptor
was shown to take-up legionellae in an indirect fashion, while CR3 directly
bound L. pneumophila to monocytes. As all the monoclonal antibodies
used in this study were o f IgG origin, it was necessary to block the Fc
receptor of the U-937 cells prior to the addition of monoclonal antibodies
using goat anti-rabbit serum to U-937 cells. Binding of the organism was
unaffected by the presence of this antibody at the host cell surface
indicating th a t as expected, as expected the Fc receptor was involved in
opsonin-independent binding.
The present data indicated that the CR molecules (CD 35 of CR1; CD
1lb and CD 18 of CR3; CD 1lc and CD 18 of CR4) were not involved for
either attachm ent or uptake. As described in Section 3, the chemical
nature of host cell receptors indicated that glycolipids (carbohydrate
and/or lipid), rather than proteins or glycoprotein structures such as CR1,
CR3 and CR4 were involved in the binding legionellae by this ‘ alternate'
non-complement mechanism. In addition, the bacterial adhesin would
appear to be protein or glycoprotein-like in nature (Section 2).
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During the first recognition of this organism by alveolar macrophages
and prior to the initiation of disease, the environment of the lung and the
alveoli contains few opsonins as shown by analysis of lavage fluids (145). In
the present model, it is suggested that CR components are not the primary
host cell receptors to which L. pneumophila bind in the earliest phases of
disease. Indeed, it would seem likely that this non-opsonic uptake would be
of grater im portance until cellular dam age has occurred and opsonin
levels increase in the lungs. Whether a given cell can take up Legionella
organisms by a non-opsonic process simultaneously with opsonin-mediated
mechanisms is not known. However, unlike studies in which complement
components are excluded and therefore only opsonin-independent
processes are assessed, experiments conducted in the presence of
complement do not exclude the possibility of opsonin-independent uptake
from occurring also. Indeed, it seems probable that in experiments
conducted with serum or com plem ent present, organisms may enter the
cell by both processes. Whether the intracellular fate of the organism
differs under these circumstances is unknown, but it may be speculated
that since a full cycle o f cell infection occurs in the absence of opsonins
that opsonin-independent uptake may be the major route leading to
intracellular replication of the organism and eventual death of the cell.
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SECTION V

CONCLUDING REMARKS

5.1 General Conclusions
Legionella pneumophila is a facultative intracellular bacterial
pathogen responsible for the potentially fatal illness Legionnaires' disease.
This organism has previously been shown to infect a wide variety o f host
cells including amoebae, epithelial cells, fibroblasts, macrophages and
monocytes (59,94,99, 122, 134, 147, 187). However, following exposure
and inhalation by humans, legionellae preferentially infect alveolar
macrophages in the lung (183). The processes by which L. pneumophila
infects macrophages and monocytes has been shown to be dependent
on the deposition of com plem ent on the MOMP of these organisms and
the opsonized bacteria are taken-up via CR1 and CR3 (12). In the present
work an alternative process for Legionella attachm ent to host cells have
been identified and the molecules involved in adherence has been
partially characterized. This process occurred in a fashion independent of
com plem ent, opsonization or com plem ent receptors. Opsoninindependent attachm ent occurred independent of cytochalasin
treatm ent of host cells and wash-resistant, suggesting that this type of
binding occurred independent of phagocytosis and the MIP protein and
that attachm ent has proceeded beyond the weak
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erelectrostatic or Van der Waals forces responsible for early host cellpathogen interaction. This attachm ent mechanism led to com plete
replication and release of organisms in the macrophage-like U-937 cell and
was similar in to other published studies on the ultrastructural events and
m ultiplication kinetics of L. pneumophila in other host cells (75, 111, 152).
These studies describe an adhesive structure for L. pneumopNIa that
was responsible for direct cell infection and indicated that the molecule
was a complex of protein and carbohydrate and/or lipid moieties and
which possessed lectin-like activities. The host-cell receptor for binding L.
pneumophila was comprised of carbohydrate and lipid in the absence of
proteins. As the com plem ent receptors CR1 and CR3 are glycoproteins on
m acrophage surface membranes and are believed to be solely
responsible for the docking L pneumophila, carbohydrate oxidation and
proteolytic m odification should inhibit organism binding. As this was not the
case it suggested receptor structure other than com plem ent receptors.
Monoclonal antibodies specific for CR1, CR3, CR4 and their subunits
demonstrated that these cell-expressed components were not involved in
opsonin-independent binding to macrophages. These antibodies did not
inhibit L. pneumophila binding to U-937 cells.
It is postulated that such an alternative mechanism of binding is
central to the initial establishment of cell infection in the human lung.
Clinical evidence to support this suggestion indicates that the lung are
essentially devoid of complement (145). If disease is to becom e
established in the lung non-opsonin-mediated processes would need to
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occur. The identification of alternative attachm ent mechanisms and the
isolation and purification of the molecules responsible for attachm ent of L
pneum ophila by macrophages may prove useful for the production of
vaccines. Such vaccines would be of major advantage for augmenting
current antimicrobial strategies especially since antibiotics unlike vaccines
neither prevent infection nor reduce the mortality arising from
Legionnaires' disease.

5.2 Future Studies
Host infection with L. pneumophila is a complex series of events and
expression of bacterial virulence factors as well as the status of the immune
system of the host are central to the initiation and development of this
disease. Several interesting lines of inquiry emerge from the present study
and these merit further investigation:

1- A panel of monoclonal antibodies should be raised against
Legionella surface proteins to challenge the organism-host cell binding
event to define those structures as potential adhesins.

2- Identification of the genes responsible for the expression of
adherence factors on L. pneumophila should be conducted. The
generation of isogenic strains o f L. pneumophila that do not express the
adhesin should by undertaken and these m utant strains should be tested
for binding potential.
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3- The role of com plem ent receptors in the establishment of disease
requires clarification. Mutants o f L. pneumophila carying different
genotypic markers but possessing similar binding and intracellular growth
characteristics as parent strains should be developed and used to
differentiate which receptors are preferentially used for uptake by this
organism. In such syudies, one genotype could be added to cells without
opsonins and the different genotype could be added with com plem ent
and serum and the progeny assayed to determine which replicated
intracellularly. These studies may resolve whether organisms takervup by
com plem ent-m ediated processes are destroyed or eventually lead to cell
infection.

4- The role of cytokines and other immune function modulators
should be assessed for their part in the bacterial infectious process at the
cellular and molecular levels. It may prove feasible for those with inhibitory
effects to be used in association with conventional therapy to augment
antibiotic therapy.

5- The role of B and T cells in immunity is unclear. Data on the
recognition events by T cells as well as the influence of specific antibody in
long term immunity is required. These studies may profoundly influence
vaccine development.

6- The interaction of legionellae with environmental am oebae
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should be investigated to determine whether the binding processes
characterized in the present study are conserved in nature. Such studies
would assist with our understanding of human disease, as well as survival of
the organism in the supernatant.

7- The part played by the major secretory protein of L. pneumopNIa,
the zinc metaloprotease, as well as, other exotoxic products produced by
the organism should be determined for the part these compounds play in
virulence both a t the cellular level and in the development of human
Legionnaires' disease.
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APPENDICES

Appendix 1; Biological Studies
A. Bacterial Cultivation
1.1. Storage o f Bacterial Cultures
Legionella pneumophila serogroup 1 strain N7 is a virulent strain of
this organism. Organisms were stored at -70°C throughout this study.
Thawed alliquots grown on buffered charcoal yeast extract agar (BCYE-a)
were periodically assessed for virulence using the fertile hens egg model
(Tzianabos).

1.2. De-ionized water
All water used in these studies were obtained from a MillhQ filtration
system (Millipore). Water was collected from the outflow port after ten
megaohm resistivity was reached. The w ater was passed through a 0.2 urn
sterile filter and stored a t 4°C in the dark.

1.3. Buffered Charcoal Yeast Extract Agar (BCYE-a)
The preferred agar for the cultivation of Legionella is BCYE-a agar.
This media was purchased in dehydrated form from Becton Dickinson
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(Cockeyesville, MD) and is resuspended in Milli-Q water. The formulation
ofthis agar is as follows:

Component

Amount (g/L)

Yeast Extract
ACES Buffer
Ferric FVrophosphate
a-ketoglutarate
Agar
Activated Charcoal

10.0
10.0
0.25
1.0

15.0
2.0

To 800 ml of fresh Milli-Q water 38.3g of BCYE-a was added and
mixed until dissolved. A volume of ION KOH was added dropwise to the
agar solution to adjust the pH to 6.9. The final volume was adjusted to 1 liter
by adding Milli-Q water. The agar was sterilized by autoclave using 121°C
a t 12 psi for 20 min and the m edia was allowed to cool to 52°C. 4 ml of a
10% L-cysteine in Milli-Q water was added to each liter, was evenly
distributed throughout the m edia and plates were poured. After the plates
cooled, they were placed in an incubator a t 37°C overnight to check for
sterility and were stored at 4°C in a sealable plastic bag containing moist
paper towels until needed.

1.4. Buffered Yeast Extract Broth (BYE-a)
BYEa- broth was used in this study to grow legionellae from plate
cultures. This media was the standard broth for L. pneumophila cultivation
and was not supplemented with antimicrobials. The formulation used was:
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Component

Amount (a/L)

Yeast Extract
ACES Buffer
Ferric pyrophosphate
a-ketoglutarate

10.0
10.0

0.25
1.0

These components were added in sequence to 800 ml of Milli-Q
water. The broth was then adjusted to pH of 6.9 with the dropwise addition
of 10N KOH and the total volume was adjusted to 1 liter with fresh Milli-Q
water. The BYE-a broth was filtered through a 0.45 nm filter and then
through a sterile 0.22 nm filter for final sterilization. 4 ml of a 10% L-cysteine
solution was added per liter and this was alliquoted into 5 ml batches and
tested for sterility in a similar manner to BCYE-a agar.

1.5. Phosphate Buffered Saline (PBS)
This isotonic buffer was used in various studies for washing bacteria
as well as host cells and was m ade in Milli-Q water. The formulation used
was:
Component

Amount (a/L)
8.0
0.2
0.2
0.15

NaCI
KCI

KH2PO4
Na2HP04

PBS was adjusted to a pH of 7.2 by addition of 10N NaOH and was
sterilized by autoclaving. Solutions were stored at 4°C in 500 ml batches in
the dark until needed.

149

1.6. 1% Peptone
1 g o f peptone was disotved in 100 ml of Milli-Q water. The solution
was sterilized by autoclaving and was then aliquoted in 0.9 ml volumes with
a Cornwall syringe into sterilized standard type dilution blank test tubes.
These 0.9 ml dilution blanks were stored overnight at 4°C prior to use.

B. Cell Culture
1.7. De-tonized water
See appendix 1.2 above.

1.8 . Hank's Balanced Salt Solution (HBSS)
Sterile batches of 500ml lOx concentrated HBSS with supplemented
phenol red was purchased from Sigma (Sigma, St. Louis MO). To 450 ml of
sterile Milli-Q water, 50 ml of sterile HBSS was added. The pH of this solution
was adjusted to 7.2 with sterile 1N Na2HC0 3 . These batches were tested
for sterility by placing the prepared bottles at 37°C for 24 h. Furthermore, a
0.1 ml sample of HBSS was plated on both nutrient and blood agar and
these plates were checked for sterility following 24 h incubation at 37°C.
Sterile HBSS was stored at 4°C until needed.

1.9. Glutamine
L-glutamine was purchased in sterile 100 ml batches a t a
concentration of 200 mM in water (Sigma) and was stored a t -20°C until
needed.
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1.10. Fetal Bovine Serum
Sterile fetal bovine serum (Hybrimax) was purchased from Sigma in
500 ml batches. The contents of each bottle was thawed and alliquoted
into 25 ml batches in sterile 50 ml conical tubes and stored a t -20°C until
needed.

1.12. Sodium bicarbonate
A 7.5% sodium bicarbonate solution was prepared by adding 7.5 g
Na2HC0 3 to 100 ml fresh Milli-Q water. This was filter sterilized by positive
pressure filtration through a 0.22 jim membrane filter into a sterile 100 ml
dilution bottle and was stored at 4°C until needed.

1.12. Sodium Hydroxide
A IN NaOH was prepared by adding 4g NaOH pellets to 100ml
distilled water and this solution was sterilized by autoclaving.

1.13. RPMI-1640
U-937 cells and guinea pig alveolar macrophages were cultivated in
RPMI-1640 without antibiotics. Basal RPMI-1640 cell culture media
containing phenol red was purchased as lOx stock solutions in 500 ml
alliquots from Sigma and were stored a t -20°C. For culture, the basal
m edia was prepared in 500 ml batches as follows:
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Component

Amount

W ater
RPMI-1640
FBS
L-glutamine
7.5% Sodium bicarbonate

377ml
50ml
50ml
18ml
5ml

The RPMI-1640 medium was adjusted to pH 7.2 with NaOH. Samples
of each media were batch tested for sterility by adding 0.1 ml alliquots of
cell culture media to both nutrient and blood agar plates. These plates
were incubated overnight at 37°C and examined the following morning.
Sterile m edia was stored at 4°C.
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Appendix 2; Electron Microscopy
A. Transmission Electron Microscopy
2.1. Grids
Copper grids of 400 mesh were purchased from Electron
Microscopy Supplies (EMS) and were used for all studies.

2.2. Collodion
A stock solution collodion was purchased as 10% nitrocellulose
dissolved in EM grade amyl acetate. This solution was diluted to 1%with EM
grade amyl acetate and stored at room temperature in the dark.

2.3. Collodion Coating of Grids
3 drops of collodion solution were dropped onto the surface of a
standard petri dish containing 20 ml Milli-Q water. The lid was placed over
the to p of the dish in canted fashion to prevent dust accum ulation on the
films and to permit evaporation of amyl acetate resulting in the production
of ultra-thin collodion films. Copper grids were place face down on the
collodion films using forceps and were collected using dust-free parafilm.
Collected copper grids were allowed to dry at room temperature
overnight prior to use.
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2.4. C acodylate buffer
0.1M cacodylate buffer (Electron Microscopy Sciences) was m ade
by adding 21.4 g sodium cacodylate-trihydrate to 1 L Milli-Q water. Then 10
mM MgSOj was added to this solution. Cacodylate buffer was adjusted to
pH 7.4 and stored in the dark at 4°C until needed.

2.5. Glutaraldehyde
EM grade glutaraldehyde was purchased from EMS as a 50% solution
and was stored refrigerated, in the dark. Prior to TEM and SEM studies,
glutaraldehyde was diluted to 3% in cacodylate buffer and was used for
specimen fixation. Glutaraldehyde was used in a fume hood.

2.6. Osmium Tetroxide
Osmium tetroxide was purchased as a solid from EMS in glass vials in
vacuo and were stored a t 4°C. Working strength osmium tetroxide was
prepared by placing the contents of a 1 g vial in 50 ml cacodylate buffer
to make a 2% (w/v) stock solution. Equal volumes of 2% osmium solution
and cacodylate buffer were placed over each sample and they were
fixed overnight a t room temperature. OSO4 was used in a fume hood and
waste was disposed of in proper fashion according to University policy.

2.7. G raded Ethanol Series
Absolute ethanol was diluted with cacodylate buffer to create a
series of 50%, 70%, 75%, 90% and 95% ethanol. Each dilution was stored in
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sealed bottles and was kept at room temperature.

2.8. Propylene Oxide
Propylene oxide was purchased from EMS ready for use and was
stored tightly stoppered in a cool dark place.

2.9. Resins
An epon-arlydite resin mixture was used to em bed specimens for thin
sectioning. All resin components were purchased from EMS and were
stored a t room temperature in the dark. The recipe and proportions used
in there studies were as follows:
Resin

Proportion

Epon812
Araldite
Dodecyl succinic anhydride
Dibutyl phthalate (plasticiser)
DMP-30 (accelerator)

5 parts
11 parts
3 parts
0.8 parts
0.4 parts

All resins were measured using plastic tri-pour beakers or plastic
syringes. The resins were added in sequence to a glass bottle (except for
the DMP-30) and were shaken vigorously for 10-15 min. The resin mixture
was divided into 4 equal parts and was com plete by the addition of DMP30 a t the appropriate concentration (see TEM procedure 2.10). The
com plete resin was then shaken for an additional 3 min to facilitate even
distribution of DMP-30. All manipulations were performed in a fume hood.
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2.10. TEM Procedure
Cell cultures in T-75crr>2 flasks either infected with Legionella or non
infected were fixed in situ with 3% (w /v) glutaraldehyde for 2 h. Samples
were not allowed to dry a t any stage o f the em bedding process. Following
fixation, cells were washed 10 times with cacodylate buffer and were
scraped from the surface of the flask using a silicon rubber-coated pipette.
The samples were lightly pelleted in an eppendorf tube and supernatants
were decanted. Samples were then em bedded in 2% nobel agar and
fixed overnight in 1% (w/v) osmium tetroxide.
Washed, osmicated samplest were dehydrated using a graded
ethanol series of 50%, 70%, 75%, 90%, 95% at 5 min each to reach absolute
ethanol followed by two changes of 10 min each in absolute ethanol. The
samples were further dehydrated in propylene oxide with 2 changes o f 10
min each. Following the preparation of the epon-aryldite resin mixture, a
gradient resin series was m ade to facilitate impregnation of specimens.
The samples were placed in each step of a gradient consisting of 1 part
resin and 2 parts propylene oxide for 1 h and then 2 parts resin resin and 1
part propylene oxide for 1 h. Samples were then placed in 100% resin and
then into 100% degassed resin for 1 h each.
Agar em bedded, resin impregnated samples were placed at the
bottom of a beam capsule, one specimen per capsule, using a wooden
dowel trimmed to form a spatula-like end. In addition, paper labels marked
with lead pencil were placed into each of the appropriate capsules.
Samples were covered with com plete degassed resin and were
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polymerized in a 60°C oven for 24 h. Blocks were removed from capsules
after 48 h and allowed to fully harden. Blocks were trimmed and ultra-thin
60-90 nm section cut with a LKB uitratome III ultramicrotome using a Diatom
diam ond knife. Sections were collected on 400 mesh copper grids.
Sections were stained with uranyl acetate for 1 min., washed with 20 ml of
boiled, cooled Milli-Q water and the stained with lead citrate for 30 sec.
followed by 50 ml rinsing with boiled, cooled milli-Q water. After drying,
stained grids were observed and photographed on a Hitachi scanningtransmission electron microscope in the transmission m ode at an
accelerating voltage of 75kV.

2.11. Uranyl acetate staining
Uranyl acetate was purchased from EMS and was stored at room
temperature in the dark. A 5% stain solution was made by placing 1 g
uranyl acetate in 20 ml sterile filtered Milli-Q water. After allowing overnight
to dissolve, the stain was filtered through a 0.45 nm filter into a clean, dry,
screw-top tube and was stored a t room temperature covered with
aluminum foil.

2.12. Lead citrate staining
A sodium hydroxide pellet was dissolved In 15 ml boiled, cooled Millh
Q water. A 0.5% lead citrate solution was m ade by placing 0.1 g lead
citrate into the 15 ml solution and this was followed by the addition of 10 ml
boiled, cooled Milli-Q water. After sitting overnight to fully dissolve, 1 ml
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alliquots were centrifuged a t 12,400 x g for 20 min and supernatants were
stored a t room temperature, in the dark, wraped in foil until needed.

B. Scanning Electron Microscopy
2.13 Hexamethyldisalizane (HMDS)
HMDS was purchased from EMS in ready to use form. This highly
volatile substance was stored tightly stoppered and stored in a cool dark
place.

2.14 SEM Procedure
Samples in 6 well plates on coverslips were fixed with 3%
glutaraldehyde for 2 h. Following fixation, samples were washed
extensively with PBS and dried in a graded ethanol series in situ (50%, 70%,
75%, 90%, 95% and 100%) in similar fashion to TEM studies (Appendix 2.10).
Specimens on coverslips were dried from hexamethyldisalazane (HMDS)
were fixed on the to p of a carbon coated stub and were stored a t room
temperature in a desiccated environment. The coverslips were placed in
a sputter coater and were coated with 20 nm gold-palladium using a
target to specimen distance of 5 cm and 15 mA for 4 min. Specimens
were placed in an AMR-1000 scanning electron microscope with an
accelerating voltage of 60kV.
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Appendix 3: Guinea Pla Care and Alveolar Macrophage Collection

All animal procedures were conducted according to NIH guidelines
as governed by the University of New Hampshire, Animal Care and Use
Committee. Experiments were performed under the licence 930803 and
its predicessors issued to Dr. Frank G. Rodgers.

3.1. Animal Specifications
Hartley outbread guinea pigs (either sex) of 600-650 g were
purchased from Charles River Laboratory. The animals were shipped in
one day in filtered cartons. Upon arrival, each animal was checked for
general appearance, sexed, weighed, fed as needed and placed into a
separate cage to stablize.

3.2. Animal Living Conditions
All cages conform ed to Animal Care and Use Committee guidelines
for size. In addition, each cage contained a generous amount of wood
chips which were changed on an animal to animal need basis.

3.3. Food and Water
Guinea pig chow (Ralston Purina) and water were supplied to
animals a d libitum.
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3.4. Euthanization
Each animal was weighed and sacrificed prior to collection of
alveolar macrophages with an intraperitoneal injection of nembutal
(sodium pentobarbitol). Animals were then bleed by laceration of the
dorsal aorta and descending vena cava to limit the amount of blood in
m acrophage cultures. Following collection of macrophages, each animal
was delivered to UNH animal facilities for proper disposal.

3.5. Collection of Alveolar Macrophages
Following exsanguination, the trachea was exposed and clam pedoff using a hemostat to prevent descending contam ination of cultures and
to restrict fluid motion in the respiratory tract. A 10 ml syringe with an 15gauge needle containing ice-cold HBSS (pH 7.2) was inserted into the
trachea and the contents of the needle was slowly expelled into the lungs.
Following a 1-2 min incubation, the fluid was removed by aspiration with the
same syringe. This procedure was repeated a total of four times per
animal. Collected samples were placed on ice until they were processed.
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